{
  "url": "https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6",
  "title": "Megasphaera contributes to lactate-driven valerate production in the human gut - Microbiome",
  "description": "Background The human gut microbiota produces short-chain carboxylic acids (SCCA) through fermentation of undigested carbohydrates, and through chain elongation, a process that can be modulated through diet. Valerate is frequently recovered from human fecal samples, but little is known about dietary components, microbial contributors, and cross-feeding interactions that drive human intestinal valerate formation. We combined co-culture studies and in vitro human fecal microbiota batch fermentations (n = 20) with the analysis of a free-living cohort of obese and overweight women (n = 49) that monitored and modified (fermented) dairy consumption, to study the role of dairy-derived lactose and lactate in intestinal microbial formation of valerate. Results While the valerate producer Megasphaera elsdenii was not able to use lactose in single culture, valerate was formed (6.2 ± 1.3 mM) in co-culture with the lactose-utilizing and lactate-producing food microbe Streptococcus thermophilus. In vitro, valerate was produced by fecal microbiota of most donors (15/20) in control medium. Lactose addition significantly (p < 0.05) increased valerate formation of fecal microbiota that harbored Megasphaera at levels ≥ 5 log cells/mL (n = 4), while valerate formation was lower when Megasphaera was less abundant or not detected (n = 15). The addition of M. elsdenii to batch fermentations increased valerate production in 80% of samples and correlation analysis showed a positive correlation (p < 0.001) between relative abundance of Megasphaera and valerate levels. In vivo, 30% of study participants harbored Megasphaera based on 16S rRNA gene amplicon sequencing and species-specific qPCR. Diet supplementation with drained yogurt (skyr) led to higher fecal microbial diversity (p < 0.05) and relative abundance of Streptococcaceae. Participants that harbored Megasphaera and consumed skyr daily had significantly (p < 0.05) higher fecal valerate levels at week 6 compared to controls. In addition, fecal levels of lactate were higher in the skyr compared to the control group at 12 weeks. Linear discriminant analysis suggested co-occurrence of Megasphaera with the lactate-producer Lactobacillus and competition with other lactate utilizers such as the Anaerobutyricum hallii group. Conclusion This study brings forward new mechanistic understanding on the intestinal microbial formation of the SCCA valerate. Our findings identified Megasphaera as an infrequently occurring and low abundant keystone taxon contributing to lactose/lactate-driven valerate production in overweight/obese women. Our results highlight that the presence of Megasphaera affects the fermentative response to daily consumption of fermented dairy. Video Abstract",
  "links": [
    "https://link.springer.com/article/10.1186/s40168-025-02207-6",
    "https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6"
  ],
  "image": "https://static-content.springer.com/image/art%3A10.1186%2Fs40168-025-02207-6/MediaObjects/40168_2025_2207_Fig1_HTML.png",
  "content": "<div>\n                                    <div><h2 id=\"Sec1\">Introduction</h2><div><p>The human gut provides an ecosystem to a vast and diverse microbial community consisting of up to 10<sup>11</sup> microorganisms [<a target=\"_blank\" title=\"Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14: e1002533.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR1\">1</a>]. The intestinal microbiome plays a critical role in maintaining and mediating health and disease through metabolic activities and interactions with the host [<a target=\"_blank\" title=\"Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165:1332–45.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR2\">2</a>]. The gut microbiota contributes to the hydrolysis of undigestible complex carbohydrates to release mono- and disaccharides that are available for fermentation. The short-chain carboxylic acids (SCCA) formate, succinate, lactate, and acetate are formed as fermentation intermediates and can be further metabolized to propionate and butyrate [<a target=\"_blank\" title=\"Culp EJ, Goodman AL. Cross-feeding in the gut microbiome: ecology and mechanisms. Cell Host Microbe. 2023;31:485–99.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR3\">3</a>,<a target=\"_blank\" title=\"Louis P, Duncan SH, Sheridan PO, Walker AW, Flint HJ. Microbial lactate utilisation and the stability of the gut microbiome. Gut Microbiome. 2022;3: e3.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR4\">4</a>,<a target=\"_blank\" title=\"Reichardt N, et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 2014;8:1323–35.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR5\">5</a>,<a target=\"_blank\" title=\"Elvan Gezer M, et al. Investigation on L-rhamnose metabolism of Loigolactobacillus coryniformis subsp. coryniformis DSM 20001 and its propionate-containing fermentates. Appl Environ Microbiol. 2024;91:e01613-24.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR6\">6</a>,<a target=\"_blank\" title=\"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19:29–41.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR7\">7</a>] (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig1\">1</a>). Butyrate and propionate have well-documented health benefits through interaction with the intestinal immune system, as an energy source for colonocytes, and as compounds with antimicrobial properties [<a target=\"_blank\" title=\"Wells JM, et al. Homeostasis of the gut barrier and potential biomarkers. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2017;312:G171–93.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR8\">8</a>]. While SCCA with <i>n</i> ≤ 4 carbons in the backbone structure are produced by fermentative pathways, SCCA with five (valerate) and six (caproate) carbons are formed by chain elongation [<a target=\"_blank\" title=\"Wang J, Yin Y. Biological production of medium-chain carboxylates through chain elongation: an overview. Biotechnol Adv. 2022;55: 107882.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR9\">9</a>] through condensation of an acceptor molecule, e.g., propionate or butyrate, and acetyl-CoA [<a target=\"_blank\" title=\"de Smit SM, de Leeuw KD, Buisman CJN, Strik DPBTB. Continuous n-valerate formation from propionate and methanol in an anaerobic chain elongation open-culture bioreactor. Biotechnol Biofuels. 2019;12:132.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR10\">10</a>, <a target=\"_blank\" title=\"Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol. 2004;70:5810–7.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR11\">11</a>] (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig1\">1</a>). Valerate can also be formed as a result of Stickland reaction [<a target=\"_blank\" title=\"Barker HA. Pathway of 5-aminovalerate degradation by Clostridium aminovalericum. in Current Topics in Cellular Regulation (eds. Levine, R. L. &amp; Ginsburg, A.) vol. 26 349–354 (Academic Press, 1985).\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR12\">12</a>]. Valerate is frequently found in feces and has recently gained interest due to potential therapeutic effects. Restoring valerate levels improved health prognosis for patients with <i>C. difficile</i> infections [<a target=\"_blank\" title=\"McDonald JAK, et al. Inhibiting growth of Clostridioides difficile by restoring valerate, produced by the intestinal microbiota. Gastroenterology. 2018;155:1495-1507.e15.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR13\">13</a>], and did not alter overall community composition in an in vitro chemostat model and in vivo in mice [<a target=\"_blank\" title=\"Martinez-Gili L, et al. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites. Gut Microbes. 2020;12:1810531.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR14\">14</a>]. Valerate conferred a protective role against <i>Helicobacter pylori</i> in mice [<a target=\"_blank\" title=\"Zhai S, et al. Weizmannia coagulans BC99 affects valeric acid production via regulating gut microbiota to ameliorate inflammation and oxidative stress responses in Helicobacter pylori mice. J Food Sci. 2024;89:9985–10002.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR15\">15</a>], and was negatively correlated with the disease severity of ulcerative colitis in humans [<a target=\"_blank\" title=\"Liu M, et al. Revisiting the role of valeric acid in manipulating ulcerative colitis. Inflamm Bowel Dis. 2024;30:617–28.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR16\">16</a>]. During infancy, low fecal levels of valerate have been associated with the development of food allergies at 1 and 3 years of age [<a target=\"_blank\" title=\"Sandin A, Bråbäck L, Norin E, Björkstén B. Faecal short chain fatty acid pattern and allergy in early childhood. Acta Paediatr. 2009;98:823–7.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR17\">17</a>].</p><div><figure><figcaption><b>Fig. 1</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/figures/1\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02207-6/MediaObjects/40168_2025_2207_Fig1_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02207-6/MediaObjects/40168_2025_2207_Fig1_HTML.png\" alt=\"figure 1\" /></picture></a></div><p>Schematic depiction of fermentative utilization of carbohydrates by the adult human gut microbiota. In brief, dietary carbohydrates are enzymatically degraded in the colon and the released hexoses, pentoses and deoxyhexoses (fucose, rhamnose) can be fermented to fermentation intermediates (acetate, lactate, formate, and succinate) and final products butyrate, and propionate. In addition, alcohols and gases are produced. Fermentation of certain amino acids leads to the formation of branch chained carboxylic acids (isobutyrate and isovalerate) or valerate. Valerate and caproate can be formed by chain elongation through condensation reactions of acetyl-coA and acceptor molecules (e.g., propionate or butyrate) [<a target=\"_blank\" title=\"Culp EJ, Goodman AL. Cross-feeding in the gut microbiome: ecology and mechanisms. Cell Host Microbe. 2023;31:485–99.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR3\">3</a>,<a target=\"_blank\" title=\"Louis P, Duncan SH, Sheridan PO, Walker AW, Flint HJ. Microbial lactate utilisation and the stability of the gut microbiome. Gut Microbiome. 2022;3: e3.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR4\">4</a>,<a target=\"_blank\" title=\"Reichardt N, et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 2014;8:1323–35.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR5\">5</a>,<a target=\"_blank\" title=\"Elvan Gezer M, et al. Investigation on L-rhamnose metabolism of Loigolactobacillus coryniformis subsp. coryniformis DSM 20001 and its propionate-containing fermentates. Appl Environ Microbiol. 2024;91:e01613-24.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR6\">6</a>,<a target=\"_blank\" title=\"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19:29–41.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR7\">7</a>, <a target=\"_blank\" title=\"Wang J, Yin Y. Biological production of medium-chain carboxylates through chain elongation: an overview. Biotechnol Adv. 2022;55: 107882.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR9\">9</a>]</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/figures/1\"><span>Full size image</span></a></p></figure></div><p>Despite its relationship with several positive health outcomes, there is limited research investigating the mechanisms of microbial valerate formation in the gut and few taxa capable of the production of valerate have been identified to date [<a target=\"_blank\" title=\"Shuai M, et al. Multi-omics analyses reveal relationships among dairy consumption, gut microbiota and cardiometabolic health. eBioMedicine. 2021. \n                  https://doi.org/10.1016/j.ebiom.2021.103284\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR18\">18</a>, <a target=\"_blank\" title=\"Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. 2019;7: 91.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR19\">19</a>]. The genus <i>Megasphaera</i> can produce valerate from lactate [<a target=\"_blank\" title=\"Allegue T, et al. Lactate addition boosts valerate yields in granular mixed culture carbohydrate fermentation. J Environ Chem Eng. 2022;10: 108869.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR20\">20</a>, <a target=\"_blank\" title=\"Soto-Cruz O, Favela-Torres E, Saucedo-Castañeda G. Modeling of growth, lactate consumption, and volatile fatty acid production by Megasphaera elsdenii cultivated in minimal and complex media. Biotechnol Prog. 2002;18:193–200.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR21\">21</a>] as well as from propionate [<a target=\"_blank\" title=\"Shetty SA, Marathe NP, Lanjekar V, Ranade D, Shouche YS. Comparative genome analysis of Megasphaera sp. reveals niche specialization and its potential role in the human gut. PLoS One. 2013;8: e79353.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR22\">22</a>]. Valerate formation has been reported in vitro for the species <i>Megasphaera elsdenii</i>, <i>Megasphaera massiliensis</i>, and<i> Megasphaera hexanoica</i> [<a target=\"_blank\" title=\"Marounek M, Fliegrova K, Bartos S. Metabolism and some characteristics of ruminal strains of Megasphaera elsdenii. Appl Environ Microbiol. 1989;55:1570–3.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR23\">23</a>,<a target=\"_blank\" title=\"Yoshikawa S, et al. Valerate production by Megasphaera elsdenii isolated from pig feces. J Biosci Bioeng. 2018;125:519–24.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR24\">24</a>,<a target=\"_blank\" title=\"Zebeli Q, et al. Intraruminal administration of Megasphaera elsdenii modulated rumen fermentation profile in mid-lactation dairy cows. J Dairy Res. 2012;79:16–25.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR25\">25</a>,<a target=\"_blank\" title=\"Yuille S, Reichardt N, Panda S, Dunbar H, Mulder IE. Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid. PLoS One. 2018;13:e0201073.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02207-6#ref-CR26\">26</a>,<a target=\"_blank\" title=\"Kim H, Jeon BS, Sang B-I. An efficient new process for the selective production of odd-chain carboxylic acids by simple carbon elongation using Megasphaera hexanoica. Sci Rep. 2019;9: 11999.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR27\">27</a>]. <i>Megasphaera</i> is a common inhabitant of mammalian gastrointestinal systems and isolates have been obtained from pigs, ruminants, and humans [<a target=\"_blank\" title=\"Sugihara PT, Sutter VL, Attebery HR, Bricknell KS, Finegold SM. Isolation of Acidaminococcus fermentans and Megasphaera elsdenii from normal human feces. Appl Microbiol. 1974;27:274–5.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR28\">28</a>, <a target=\"_blank\" title=\"Stanton TB, McDowall JS, Rasmussen MA. Diverse tetracycline resistance genotypes of Megasphaera elsdenii strains selectively cultured from swine feces. Appl Environ Microbiol. 2004;70:3754–7.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR29\">29</a>], but little is known about the role of <i>Megasphaera</i> within the human gut microbiota. The valerate precursors lactate and propionate are produced intestinally through fermentation (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig1\">1</a>) and can be obtained through the consumption of food [<a target=\"_blank\" title=\"Garrote GL, Abraham AG, Rumbo M. Is lactate an undervalued functional component of fermented food products? Front Microbiol. 2015;6:629.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR30\">30</a>] fermented by <i>Lactobacillaceae</i> and other lactate-producing food cultures such as <i>Streptococcaceae</i> [<a target=\"_blank\" title=\"Gänzle M. The periodic table of fermented foods: limitations and opportunities. Appl Microbiol Biotechnol. 2022;106:2815–26.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR31\">31</a>]. Such fermented foods are consumed worldwide [<a target=\"_blank\" title=\"Gänzle M. The periodic table of fermented foods: limitations and opportunities. Appl Microbiol Biotechnol. 2022;106:2815–26.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR31\">31</a>], and are relevant sources of dietary lactate [<a target=\"_blank\" title=\"Gänzle MG, et al. Starter culture development and innovation for novel fermented foods. Annu Rev Food Sci Technol. 2024;15:211–39.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR32\">32</a>]. There is surprisingly little information on dietary lactate absorption processes in humans. In addition, fermented food can contain fermentable carbohydrates and starter cultures able to form lactate during the gastrointestinal passage [<a target=\"_blank\" title=\"Li Q. et al. In vitro investigations on the impact of fermented dairy constituents on fecal microbiota composition and fermentation activity (manuscript accepted). Microbiol. Spectr. 2025;13(3):e02193-24. \n                  https://doi.org/10.1128/spectrum.02193-24\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR33\">33</a>, <a target=\"_blank\" title=\"Pasolli E, et al. Large-scale genome-wide analysis links lactic acid bacteria from food with the gut microbiome. Nat Commun. 2020;11: 2610.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR34\">34</a>].</p><p>To shed light on the interplay of dietary and microbially formed lactate, lactate-utilizing <i>Megasphaera</i>, and intestinal microbial valerate formation, we combined co-culture experiments and in vitro fecal microbiota batch fermentations. We modulated the lactate cross-feeding and valerate formation capacity of the system through the provision of the dairy sugar lactose, lactate, and/or <i>Megasphaera</i>. Additionally, we investigated the occurrence of <i>Megasphaera</i> and in vivo valerate formation using fecal samples collected during a 3-month dietary supplementation study of a free-living cohort of overweight/obese women that included the consumption of drained yogurt (skyr) containing lactate, lactose, and a lactate-forming starter culture, <i>Streptococcus</i> <i>thermophilus</i> [<a target=\"_blank\" title=\"Correia BSB, Dalgaard LB, Thams L, Hansen M, Bertram HC. Changes in the urinary metabolome accompanied alterations in body mass and composition in women with overweight – impact of high versus low protein breakfast. Metabolomics. 2024;20: 81.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR35\">35</a>].</p></div></div><div><h2 id=\"Sec2\">Results and discussion</h2><div><h3 id=\"Sec3\">Valerate is produced by co-cultures of <i>M. elsdenii</i> and <i>S. thermophilus</i> in the presence of lactose</h3><p>To test for lactate-driven cross-feeding activity leading to valerate production, we conducted co-culture studies of <i>Megasphaera elsdenii</i> DSM 20460 with the yogurt starter culture <i>Streptococcus thermophilus</i> LMG 18311 that produces lactate from lactose [<a target=\"_blank\" title=\"Li Q. et al. In vitro investigations on the impact of fermented dairy constituents on fecal microbiota composition and fermentation activity (manuscript accepted). Microbiol. Spectr. 2025;13(3):e02193-24. \n                  https://doi.org/10.1128/spectrum.02193-24\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR33\">33</a>]. Digestion of lactose by brush‐border lactase phlorizin hydrolases and absorption take place in the small intestine. About 70% of the population worldwide are lactase non-persistent [<a target=\"_blank\" title=\"Li Q. et al. In vitro investigations on the impact of fermented dairy constituents on fecal microbiota composition and fermentation activity (manuscript accepted). Microbiol. Spectr. 2025;13(3):e02193-24. \n                  https://doi.org/10.1128/spectrum.02193-24\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR33\">33</a>], allowing for lactose to reach the lower gastrointestinal tract. Strains were grown alone and in co-culture in anaerobically prepared yeast casitone (YC) medium that contained acetate, propionate, isobutyrate, isovalerate, and valerate (traditionally used term, fatty acids (FA)) [<a target=\"_blank\" title=\"Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002;68:5186–90.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR36\">36</a>] and that was additionally supplied with 40 mM lactose (YCFA-L) at 37 °C for 48 h. We measured turbidity using a McFarland densitometer as an indicator of growth and determined substrate utilization and metabolite formation using high-performance liquid chromatography with refractive index detector (HPLC-RI). Consumption and production were calculated as difference between levels determined at the individual time points and the original concentration at the beginning of incubation. We determined pH, which is indicative of the formation of SCCA during growth.</p><p>Within 48 h, <i>S. thermophilus</i> grew in YCFA-L (9.6 ± 1.0 MF units), used 25.6 ± 8.6 mM lactose, and accumulated 22.8 ± 3.0 mM galactose while producing 41.0 ± 9.0 mM lactate (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig2\">2</a>A–B) leading to a final pH of 4.9 ± 0.1. When inoculated alone, <i>M. elsdenii</i> reached 3.3 ± 0.3 MF units (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig2\">2</a>A) and produced minor amounts of butyrate (4.0 ± 0.5 mM), acetate (2.5 ± 4.5 mM), and lactate (1.2 ± 0.2 mM). Propionate present in the medium was used (− 1.9 ± 6.5 mM); the final pH was 6.0 ± 0.4 (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig2\">2</a>C). The co-culture reached a turbidity of 10.6 ± 0.0 MF units (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig2\">2</a>A), used 29.2 ± 5.9 mM lactose, and accumulated 27.7 ± 3.2 mM galactose. Butyrate (24.3 ± 1.5 mM) and valerate (6.2 ± 1.3 mM) were formed after 48 h inoculation, while propionate was consumed (− 5.1 ± 4.2 mM) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig2\">2</a>D). An accumulation of lactate (7.1 ± 1.7 mM) was only observed at 24 h (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig2\">2</a>D), and the final pH was 5.5 ± 0.1.</p><div><figure><figcaption><b>Fig. 2</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/figures/2\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02207-6/MediaObjects/40168_2025_2207_Fig2_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02207-6/MediaObjects/40168_2025_2207_Fig2_HTML.png\" alt=\"figure 2\" /></picture></a></div><p>Growth, substrate utilization, and metabolite formation of <i>S. thermophilus</i> and <i>M. elsdenii</i>. <i>S. thermophilus</i> LMG 18311 and <i>M. elsdenii</i> DSM 20460 were grown alone and in co-cultures in YCFA-L containing 40 mM lactose for 48 h at 37 °C. Turbidity was monitored using McFarland densitometer (MF units). Substrate utilization and metabolite (mM) formation were recorded with HPLC-RI and calculated from initial values (time 0 h). <b>A</b> Turbidity during growth. <b>B-D</b> Substrate utilization and metabolite formation of <b>B</b> <i>S. thermophilus</i>, <b>C</b> <i>M. elsdenii</i>, and <b>D</b> Co-cultures of <i>S. thermophilus</i> and <i>M elsdenii</i>. Results shown are biological triplicates from independently prepared working cultures with standard deviations</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/figures/2\"><span>Full size image</span></a></p></figure></div><p>Taken together, our results highlight efficient cross-feeding between a food-related lactate producer and <i>M. elsdenii</i> that yielded butyrate and valerate. In our study, <i>M. elsdenii</i> could not use the galactose that was released by <i>S. thermophilus</i> [<a target=\"_blank\" title=\"Lanjekar VB, Marathe NP, Ramana VV, Shouche YS, Ranade DR. Megasphaera indica sp. nov., an obligate anaerobic bacteria isolated from human faeces. Int J Syst Evol Microbiol. 2014;64:2250–6.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR37\">37</a>] even though some strains might have the potential to at least partly ferment galactose [<a target=\"_blank\" title=\"Marounek M, Fliegrova K, Bartos S. Metabolism and some characteristics of ruminal strains of Megasphaera elsdenii. Appl Environ Microbiol. 1989;55:1570–3.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR23\">23</a>]. Prabhu et al. identified acetate and propionate as the main metabolites under batch conditions [<a target=\"_blank\" title=\"Prabhu R, Altman E, Eiteman MA. Lactate and acrylate metabolism by Megasphaera elsdenii under batch and steady-state conditions. Appl Environ Microbiol. 2012;78:8564–70.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR38\">38</a>] while Yoshikawa et al. observed differences in propionate formation between strains [<a target=\"_blank\" title=\"Yoshikawa S, et al. Valerate production by Megasphaera elsdenii isolated from pig feces. J Biosci Bioeng. 2018;125:519–24.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR24\">24</a>]. Here, propionate did not accumulate when <i>M. elsdenii</i> was grown in single culture and in co-culture most likely due to direct chain elongation to valerate.</p><h3 id=\"Sec4\">Valerate formation is a common trait of fecal microbiota in vitro</h3><p>As our in vitro co-culture results indicated that <i>M. elsdenii</i> can produce valerate from lactate that was derived from cross-feeding, we conducted in vitro batch fermentations using fecal microbiota as inoculum to determine the valerate-forming capacity of <i>Megasphaera</i> within a complex community. We collected fecal slurries of healthy donors that were between 20 and 51 years old with regular eating patterns and bowel movements, which we considered as at least 3 meals/day, 7 days/week, and defecation once every 3 days to 3 times per day [<a target=\"_blank\" title=\"Brenner DM, Corsetti M, Drossman D, Tack J, Wald A. Perceptions, definitions, and therapeutic interventions for occasional constipation: a Rome working group consensus document. Clin Gastroenterol Hepatol. 2024;22:397–412.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR39\">39</a>]. Donor microbiota D1–D20 were cultured in anaerobically prepared modified Macfarlane medium [<a target=\"_blank\" title=\"Høgsgaard K, et al. Fucose modifies short chain fatty acid and H2S formation through alterations of microbial cross-feeding activities. FEMS Microbiol Ecol. 2023;99: fiad107.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR40\">40</a>] without (MF-C) and with lactose addition (MF-L, 10 mM) to support lactate-based cross-feeding. Fermentations were initiated with a 1% (v/v) fecal slurry inoculum and incubated at 37 °C for 48 h (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>A). Substrate utilization and metabolite formation were analyzed with HPLC-RI. In vitro batch fermentations D1–D10 were also part of a previous study with a different aim [<a target=\"_blank\" title=\"Li Q. et al. In vitro investigations on the impact of fermented dairy constituents on fecal microbiota composition and fermentation activity (manuscript accepted). Microbiol. Spectr. 2025;13(3):e02193-24. \n                  https://doi.org/10.1128/spectrum.02193-24\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR33\">33</a>].</p><div><figure><figcaption><b>Fig. 3</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/figures/3\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02207-6/MediaObjects/40168_2025_2207_Fig3_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02207-6/MediaObjects/40168_2025_2207_Fig3_HTML.png\" alt=\"figure 3\" /></picture></a></div><p>In vitro fecal batch fermentations. A total of 20 fecal samples were collected and cultured (1%) in Macfarlane (MF) media without (MF-C) or with lactose (MF-L, 10 mM) (D1–D20). Samples D11–D20 were also cultured MF-L that was additional supplied with a fresh culture of <i>M. elsdenii</i> DSM 20460 (1%, MF-L + M), while D11–D13 and D18 were tested in MF medium containing 10 mM lactate (MF-Lac). Metabolite concentrations after 24 and 48 h of fermentation were determined by HPLC-RI and <i>Megasphaera</i> abundance was tested with qPCR. <b>A</b> Experimental set-up. <b>B</b> Concentration of short-chain carboxylic acids (SCCA) and valerate at 24 and 48 h. Significant differences in SCCA levels in fermentations MF-C and MF-L were determined with Kruskal–Wallis test with post hoc Dunn’s test: “***” 0.001. <b>C</b> Relationship of <i>Megasphaera</i> (log cell/mL) abundance and valerate concentrations in MF-C and MF-L after 48 h, <i>R</i> value, and <i>p</i> value from Spearman correlation test. <b>D</b> Impact of <i>M. elsdenii</i> addition on <i>Megasphaera</i> counts in D11–D20 at the beginning (<i>t</i> = 0) and after 48 h of fermentation in MF-L and MF-L + M, dashed line, detection limit. <b>E</b> Valerate formation of donor microbiota D11–D20 in MF-C, MF-L, and MF-L + M after 48 h fermentation was measured by HPLC-RI. <b>F</b> Heatmap of Spearman correlation test between the top 25 genera in the βin vitro fecal batch fermentations with metabolites acetate, butyrate, propionate, and valerate formed after 48 h incubation. Asterisks denote significance levels (* <i>p</i> &lt; 0.05, **<i>p</i> &lt; 0.01, ***<i>p</i> &lt; 0.001)</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/figures/3\"><span>Full size image</span></a></p></figure></div><p>In MF-L, the major part of lactose was consumed within 24 h of incubation (7.3 mM, 81%) and significantly more butyrate was produced at 24 and 48 h (<i>p</i> &lt; 0.005) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>B) in agreement with previous results [<a target=\"_blank\" title=\"Li Q. et al. In vitro investigations on the impact of fermented dairy constituents on fecal microbiota composition and fermentation activity (manuscript accepted). Microbiol. Spectr. 2025;13(3):e02193-24. \n                  https://doi.org/10.1128/spectrum.02193-24\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR33\">33</a>]. As a high proportion of donor microbiota (15/20) produced valerate when grown in MF-C, our results suggest for the general potential of fecal microbiota to produce valerate. Unexpectantly, the addition of lactose to enforce lactate formation did not result in generally higher valerate levels, as median levels in MF-C were not significantly different from MF-L at 24 h and 48 h (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>B). In previous studies using a similar experimental set-up, lactate was formed during the first hours of fermentation [<a target=\"_blank\" title=\"Li Q. et al. In vitro investigations on the impact of fermented dairy constituents on fecal microbiota composition and fermentation activity (manuscript accepted). Microbiol. Spectr. 2025;13(3):e02193-24. \n                  https://doi.org/10.1128/spectrum.02193-24\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR33\">33</a>] both in MF-C and MF-L allowing for the formation of valerate from lactate at both conditions. Valerate can alternatively be produced through Stickland reactions of proline [<a target=\"_blank\" title=\"Xu Y, Zhu Y, Li X, Sun B. Dynamic balancing of intestinal short-chain fatty acids: the crucial role of bacterial metabolism. Trends Food Sci Technol. 2020;100:118–30.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR41\">41</a>, <a target=\"_blank\" title=\"Medlock GL, et al. Inferring metabolic mechanisms of interaction within a defined gut microbiota. Cell Syst. 2018;7:245-257.e7.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR42\">42</a>] or from valine, leucine, and isoleucine [<a target=\"_blank\" title=\"Akhtar M, et al. Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation. Anim Nutr. 2022;8:350–60.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR43\">43</a>]. While in intestinal systems, SCCA with a carbon backbone <i>n</i> ≤ 4 are mostly derived from carbohydrate-driven fermentation [<a target=\"_blank\" title=\"Vital M, Karch A, Pieper DH. Colonic butyrate-producing communities in humans: an overview using omics data. mSystems. 2017. \n                  https://doi.org/10.1128/msystems.00130-17\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR44\">44</a>], the predominant pathways for valerate formation have not been completely resolved.</p><h3 id=\"Sec5\">Lactose reduced valerate levels of fecal microbiota when <i>Megasphaera</i> was not detectable or present at low abundance in vitro</h3><p>To relate observations on valerate formation in vitro to microbial community composition and the occurrence of <i>Megasphaera</i>, we conducted 16S rRNA gene amplicon sequencing targeting the V3–V4 hypervariable region and determined abundance and occurrence of <i>Megasphaera</i> species by quantitative PCR. No biomass was collected from D3, and sequencing was not conducted.</p><p>At <i>t</i> = 0 h, community composition was similar in MF-C and MF-L (Suppl. Fig. S1A). After 48 h incubation, β-diversity of the microbial community was significantly different between donors and media (<i>p</i> &lt; 0.05, PERMANOVA), but not between media only (MF-C versus MF-L) based on Bray–Curtis dissimilarity matrix (Suppl. Fig. S1B). Amplicon sequence variants (ASV) assigned to <i>Megasphaera</i>, <i>Lactobacillus</i>, and <i>Bacteroides</i> were variable loadings indicative for donor microbiota D5 and D11, while <i>Escherichia-Shigella</i> were indicative for donor microbiota D15, D19, and D20 (Suppl. Fig. S1B). After 48 h incubation, the most abundant genera in fecal fermentations in MF-C were <i>Bacteroides</i> (17.0%, IQR 13.7–26.8%) followed by unclassified <i>Lachnospiraceae</i> (6.9%, IQR 5.2–15.2%) and <i>Bifidobacterium</i> (6.4%, IQR 4.0–11.8%) (Suppl. Fig. S1A). The addition of lactose led to significantly higher relative abundance of <i>Bifidobacterium</i> (+ 5.1%, <i>p</i> &lt; 0.05) and unclassified <i>Lachnospiraceae</i> (+ 3.0%, <i>p</i> &lt; 0.05), while <i>Bacteroides</i> were significantly less abundant (− 4.2%,<i> p</i> &lt; 0.05) (Suppl. Fig. S1A).</p><p><i>Megasphaera</i> was detected in 21% of donor microbiota (<i>n</i> = 4) (Suppl. Fig. S1A). With additional BLASTn analysis of representative ASV, we identified <i>M. elsdenii</i> (ASV3, ASV8, AVS25, and ASV30) and <i>M. massiliensis</i> (ASV85, ASV114) as the species contributing to <i>Megasphaera</i> occurrence. Using qPCR assays targeting <i>M. elsdenii</i> and <i>M. massiliensis</i>, we confirmed results obtained by 16S rRNA gene amplicon sequencing and identified four donors with initial <i>Megasphaera</i> counts ≥ 5 log cells/mL (D5, D6, D11, and D17), and 15 donors with low or undetectable abundance of <i>Megasphaera</i> (&lt; 5 log cells/mL) at the beginning of batch fermentations.</p><p>After 48 h, the microbiota from four donors positive for <i>Megasphaera</i> had significantly higher valerate levels in MF-L (9.1, IQR 8.6–10.1 mM) compared to MF-C (6.9, IQR 6.7–7.9 mM) (paired t-test, <i>p</i> &lt; 0.05) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>C), while valerate levels of donor microbiota without detectable <i>Megasphaera</i> were lower in MF-L (1.0, IQR 0.1–5.1 mM) than MF-C (4.4, IQR 0.1–6.8 mM) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>C). Within the microbiota from the four positive donors, counts of <i>Megasphaera</i> were higher in MF-L (8.2, IQR 7.6–8.5 log cells/mL, <i>p</i> = 0.095) compared to MF-C (7.2, IQR 6.4–8.0 log cells/mL) after 48 h fermentation (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>C). Valerate levels correlated positively with the relative abundance of <i>Megasphaera</i> (<i>r</i> = 0.37, <i>p</i> = 0.023) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>C). Based on these results, valerate formation of fecal microbiota in the presence of lactose depended on the abundance of <i>Megasphaera</i>. These observations suggest a key role of the <i>Megasphaera</i> in directing valerate formation within a fecal microbial community in the presence of specific fermentable substrates, possibly with lactate as intermediate.</p><h3 id=\"Sec6\">Supplementation of <i>Megasphaera</i> increased valerate formation in the presence of lactose</h3><p>To further test the role of <i>Megasphaera</i> in the formation of valerate via lactose/lactate, we compared in vitro batch fermentation with donor microbiota D11 to D20 (<i>n</i> = <i>10</i>) in MF-L to incubations that were additionally supplied with <i>M. elsdenii</i> DMS 20460 (1%) to MF-L at the beginning of fermentation (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>A).</p><p>At <i>t</i> = 0 h, the abundance of <i>Megasphaera</i> in batch cultures was below detection limit in most samples (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>D). The addition of <i>M. elsdenii</i> successfully modulated overall community composition (Suppl. Fig S1A) and increased median abundance of <i>Megasphaera</i> to 4.7, IQR 3.9–6.4 log cell/mL in MF-L + M. During fermentation, <i>Megasphaera</i> counts increased in 3/10 fermentations while valerate levels were higher in 80% of fermentations in MF-L + M (7.1, IQR 4.6–7.9 mM) compared to MF-L (5.5, IQR 0.0–6.8 mM, <i>p</i> = 0.2) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>E). We performed correlation analysis of relative abundance of the 25 most abundant genera and the SCCA levels after 48 h incubation to investigate a possible link between members of the microbial community to valerate levels. There was a significant correlation between the genera <i>Megasphaera</i> (<i>r</i> = 0.6, <i>p</i> &lt; 0.001), <i>Lactobacillus</i>, and <i>Lachnospiraceae</i> ND007 group (<i>r</i> = 0.4, <i>p</i> &lt; 0.01) and valerate (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig3\">3</a>F).</p><p>In previous studies, the addition of <i>M. massiliensis</i> to a synthetic consortium enabled the production of valerate [<a target=\"_blank\" title=\"Yuille S, Reichardt N, Panda S, Dunbar H, Mulder IE. Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid. PLoS One. 2018;13:e0201073.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR26\">26</a>], and lactate utilization could also be modulated in vivo in ruminants through the addition of <i>M. elsdenii</i> [<a target=\"_blank\" title=\"Zebeli Q, et al. Intraruminal administration of Megasphaera elsdenii modulated rumen fermentation profile in mid-lactation dairy cows. J Dairy Res. 2012;79:16–25.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR25\">25</a>]. Our results suggest that also within complex human fecal microbiota, the transformation of lactate to valerate depended on the presence of <i>Megasphaera</i>.</p><h3 id=\"Sec7\">The availability of lactate supports valerate formation if <i>Megasphaera</i> was present</h3><p>Lactate is a key intermediate within the intestinal microbial fermentative network and several specialist microbes use lactate and acetate to form butyrate, e.g., <i>Anaerobutyricum hallii</i> and <i>Anaerostipes caccae</i> [<a target=\"_blank\" title=\"Muñoz-Tamayo R, et al. Kinetic modelling of lactate utilization and butyrate production by key human colonic bacterial species. FEMS Microbiol Ecol. 2011;76:615–24.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR45\">45</a>], which potentially compete with <i>Megasphaera</i> for lactate. To determine whether lactate-dependent valerate formation was related to <i>Megasphaera</i> occurrence, we performed additional in vitro batch fermentations with four donor microbiota, <i>n</i> = 3 without detectable <i>Megasphaera</i> (D12, D13, D18) and <i>n</i> = 1 with <i>Megasphaera</i> (D11). We cultured fecal samples in Macfarlane medium that was supplied with 8.4 mM of lactate (MF-Lac) or without (MF-C) and performed the same analyses as outlined before, including pH adjustment to avoid antimicrobial activity of lactate. The pH was recorded at 48 h.</p><p>After 48 h, the pH of MF-C (6.4 ± 0.1) was similar to MF-Lac (6.3 ± 0.2). While donor microbiota without <i>Megasphaera</i> (D12, D13, and D18) produced valerate in MF-C (8.1, 9.5, and 4.3 mM, respectively), there was no valerate detectable after incubation in MF-Lac. In contrast, D11 produced more valerate in MF-Lac (9.0 mM) compared to MF-C (5.9 mM) (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Tab1\">1</a>). Our results suggest that the transformation of lactate to valerate within a complex microbiota depended on the presence of <i>Megasphaera</i>.\n</p><div><figure><figcaption><b>Table 1 SCCA formed during fermentation in MF-Lac compared to MF-C. Microbiota from four donors were incubated in Macfarlane alone (MF-C) or with lactate (MF-Lac, 8.4 mM). The presence of <i>Megasphaera</i> was determined with qPCR targeting the most representing species with the genus (<i>M. elsdenii</i> and <i>M. massiliensis</i>), donor microbiota with counts &lt; 5 log cells/mL were considered negative. SCCA formed after 48 h fermentation at 37 °C were determined by HPLC-RI.</b></figcaption><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/tables/1\"><span>Full size table</span></a></p></figure></div><p>For D11, butyrate formation was higher in MF-Lac compared to MF-C (Δ8.3 mM) while propionate levels were lower (− Δ8.6 mM) (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Tab1\">1</a>) indicating that valerate was formed on the expense of propionate, and that lactate addition also enhanced butyrate formation. For the other three donor microbiota D12, D13, and D18 that did not harbor <i>Megasphaera</i>, addition of lactate had comparatively less impact on butyrate and propionate formation. While previous literature reported that butyrate was the main metabolite formed in the presence of lactate [<a target=\"_blank\" title=\"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19:29–41.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR7\">7</a>, <a target=\"_blank\" title=\"Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol. 2004;70:5810–7.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR11\">11</a>, <a target=\"_blank\" title=\"Muñoz-Tamayo R, et al. Kinetic modelling of lactate utilization and butyrate production by key human colonic bacterial species. FEMS Microbiol Ecol. 2011;76:615–24.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR45\">45</a>], our results provide indication that lactate can also be transformed to valerate within a complex microbiota depending on the presence of <i>Megasphaera</i>.</p><h3 id=\"Sec8\">Daily drained yogurt consumption increased <i>Streptococcaceae</i> relative abundance in a free-living cohort of overweight/obese women</h3><p>To link our in vitro observations to in vivo data, we analyzed fecal samples from a free-living cohort study that was initially planned to investigate how overweight or obese women (body mass index (BMI) equal or above 25 kg/m<sup>2</sup>) responded to daily consumption of drained yogurt (skyr) [<a target=\"_blank\" title=\"Correia BSB, Dalgaard LB, Thams L, Hansen M, Bertram HC. Changes in the urinary metabolome accompanied alterations in body mass and composition in women with overweight – impact of high versus low protein breakfast. Metabolomics. 2024;20: 81.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR35\">35</a>, <a target=\"_blank\" title=\"Dalgaard LB, et al. No effects of high versus low protein breakfast on body composition and cardiometabolic health in young women with overweight - the NewStart randomized trial. Br J Nutr. 2014;1–30. \n                  https://doi.org/10.1017/S0007114524003015\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR63\">63</a>]. During the 12-week dietary supplementation, participants either consumed a breakfast consisting of skyr with oats (skyr group, <i>n</i> = 21), or an isocaloric dairy free breakfast (control group, <i>n</i> = 28). Participants were not required to stop (fermented) dairy consumption throughout the supplementation period. For this study, fecal samples from <i>n</i> = 49 participants (<i>n</i> = 28 and <i>n</i> = 21 in control and skyr group), were analyzed that were collected before (week 0), during (6 weeks), and after the study (12 weeks).</p><p>To study fecal microbiota composition in response to regular supplementary skyr consumption, we analyzed the microbial community using 16S rRNA gene amplicon sequencing targeting the V3–V4 hypervariable region. To account for a longitudinal study and repetitive measurements, we performed Kruskal–Wallis and post hoc Dunn’s test to compare between skyr and control group, and Friedman test with post hoc Wilcoxon test to identify significant changes during the study period within a treatment group.</p><p>Based on β-diversity analysis, dietary supplementation had a significant overall effect on the microbial communities (PERMANOVA, p &lt; 0.05 (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig4\">4</a>A), while α-diversity did not change during the study period (Fig. S2A–D). The most abundant families across all donors and sampling points were <i>Lachnospiraceae</i> (35.7%, IQR 30.2–44.3%), <i>Ruminococcaceae</i> (18.6%, IQR 15.1–22.5%), and <i>Bacteroidaceae</i> (7.8%, IQR 2.9–14.7%) (Fig. S2E). <i>Streptococcaceae</i> abundance was significantly higher in the skyr group at 6 (10.0-fold change, <i>p</i> &lt; 0.05) and at 12 weeks (4.5-fold change, <i>p</i> &lt; 0.05) compared to the control group (Fig. S2E). Within the skyr group, <i>Streptococcaceae</i> abundance significantly increased between baseline and week 6 and 12 (<i>p</i> &lt; 0.05).</p><div><figure><figcaption><b>Fig. 4</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/figures/4\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02207-6/MediaObjects/40168_2025_2207_Fig4_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02207-6/MediaObjects/40168_2025_2207_Fig4_HTML.png\" alt=\"figure 4\" /></picture></a></div><p>Microbial diversity and fecal fermentation metabolite profiles in the cohort during the supplementation. Fecal samples were collected before and during (week 0, 6, and 12) a dietary supplementation with drained yogurt (skyr, <i>n</i> = 21) or a control diet (control, <i>n</i> = 28). Microbial community profiles were determined using 16S rRNA gene amplicon sequencing, and fecal SCCA were analyzed using HPLC-RI. <b>A</b> Beta-diversity was calculated from Bray dissimilarity and presented as PCoA plot. <b>B</b> Fecal concentrations of major SCCA including valerate. <b>C</b> Differences in fecal SCCA and in the sum of acetate, propionate, and butyrate (total SCCA, µmol/g feces) at weeks 6 and 12 compared to week 0. Significant differences were identified with Kruskal–Wallis with post hoc Dunn’s test: “*” 0.05. Different letters denote differences determined with Friedmann test (<i>p</i> &lt; 0.05)</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/figures/4\"><span>Full size image</span></a></p></figure></div><p>Our results show that a daily diet supplementation with drained yogurt in a cohort of overweight/obese women that were not restricted in the consumption of dairy enhanced the relative abundance of <i>Streptococcaceae</i> and changed β-diversity but did not alter the relative abundance of any other major microbial families. These results are in agreement with a previous study that reported few overall changes in fecal microbiota composition upon the daily consumption of skyr, but observed the successful transmission of the skyr starter culture through the gastrointestinal tract [<a target=\"_blank\" title=\"Ghiamati Yazdi F, et al. Long-term daily high-protein, drained yoghurt consumption alters abundance of selected functional groups of the human gut microbiota and fecal short-chain fatty acid profiles in a cohort of overweight and obese women. J Funct Foods. 2022;93: 105089.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR46\">46</a>].</p><h3 id=\"Sec9\">In vivo, <i>Megasphaera</i> was detected in fecal samples with little response to dairy consumption</h3><p>Next, we examined for the presence of <i>Megasphaera</i> in the cohort and its response to dietary lactose/lactate uptake. Based on 16S rRNA gene amplicon sequencing, 13 participants (27%) harbored <i>Megasphaera</i> at any collection point of the study; at baseline, 18% of individuals (9/49) were identified as carriers of <i>Megasphaera</i>. We conducted BLASTn analysis of ASV classified as <i>Megasphaera</i> (ASV2073 to ASV2085), which indicated that <i>M. massiliensis</i> and <i>M. elsdenii</i> were the most abundant species in fecal microbial communities. According to qPCR targeting <i>M. massiliensis</i> and <i>M. elsdenii</i>, two more carriers were detected for a total of <i>n</i> = 15 (median 9.1, IQR 7.2–9.6 log cells/g feces) (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Tab2\">2</a>). A similar proportion of <i>Megasphaera</i> positive participants was observed in fecal samples used for in vitro<i> batch</i> fermentations in this study and in other cohorts [<a target=\"_blank\" title=\"Falony G, et al. Population-level analysis of gut microbiome variation. Science. 2016;352:560–4.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR47\">47</a>] highlighting the low representation of <i>Megasphaera</i> in the human gastrointestinal tract.\n</p><div><figure><figcaption><b>Table 2 Relationship of <i>Megasphaera</i> occurrence with dairy consumption. Fermented dairy and milk consumers were identified based on the food frequency questionnaires that were collected at weeks 0 and 12. Presence of <i>Megasphaera</i> was determined based on 16S rRNA gene amplicon sequencing and qPCR targeting <i>M. massiliensis</i> and <i>M. elsdenii.</i> To determine differences in occurrence between <i>Megasphaera</i> positive and negative microbiota, Chi-squared test was employed for categorical comparisons and no significance was found for any of the conditions. Kruskal–Wallis with post hoc Dunn’s test was used for comparison of abdundance levels. Different small letters indicate significant difference in abundance. Two participants provided no information on fermented dairy consumption at week 0 and 12, and on combined consumption at week 12</b></figcaption><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/tables/2\"><span>Full size table</span></a></p></figure></div><p>To account for the consumption of dairy products in addition to the skyr supplementation, we collected information on total dairy/milk consumption from a food frequency questionnaire that was collected at baseline (week 0) and at the end of the study (week 12). In addition to dietary supplementation with skyr (skyr group versus control), we differentiated participants as fermented dairy consumers including the skyr group, milk consumers, and consumer of dairy (milk and fermented dairy). Daily supplementation of skyr increased occurrence of <i>Megasphaera</i> from 4 to 6 participants, and there was also a non-significant increase in carriers of <i>Megasphaera</i> related to fermented dairy consumption (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Tab2\">2</a>). In a previous study, Yazdi et al. classified <i>Megasphaera</i> among the taxa that prevailed in the treatment group throughout an intervention with drained yogurt (skyr) [<a target=\"_blank\" title=\"Ghiamati Yazdi F, et al. Long-term daily high-protein, drained yoghurt consumption alters abundance of selected functional groups of the human gut microbiota and fecal short-chain fatty acid profiles in a cohort of overweight and obese women. J Funct Foods. 2022;93: 105089.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR46\">46</a>]. Similarly, Shuai et al. reported an increased abundance of <i>Megasphaera</i> in an intervention with high yogurt consumption [<a target=\"_blank\" title=\"Shuai M, et al. Multi-omics analyses reveal relationships among dairy consumption, gut microbiota and cardiometabolic health. eBioMedicine. 2021. \n                  https://doi.org/10.1016/j.ebiom.2021.103284\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR18\">18</a>]. In this study, we did not observe a significant change in occurrence and abundance but noticed that in few donors, <i>Megasphaera</i> became detectable after daily diet supplementation with skyr.</p><h3 id=\"Sec10\">Daily diet supplementation with drained yogurt increased fecal valerate levels, also in carriers of <i>Megasphaera</i>\n                        </h3><p>Next, we determined the impact of the daily skyr consumption on fecal fermentation metabolites including valerate. Fecal levels of major fermentation metabolites were determined by HPLC-RI. In feces, the predominant SCCA were acetate (35.7, IQR 26.6–47.1 µmol/g feces in skyr vs. 37.9, IQR 27.9–49.9 µmol/g feces in control), butyrate (11.8, IQR 8.2–15.6 µmol/g feces in skyr vs. 12.8, IQR 9.0–18.1 µmol/g feces in control), and propionate (4.4, IQR 0.8–8.3 µmol/g feces in skyr vs. 3.9, IQR 1.7–10.3 µmol/g feces in control), with no significant differences between diets or during the study within each group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig4\">4</a>B). There was a significant increase in total SCCA concentrations (acetate + butyrate + propionate) in the skyr group (∆<sub>week6-0</sub> 7.0, IQR − 3.0–17.4 µmol/g feces, <i>p</i> &lt; 0.05) from week 0 to week 6 compared to the control group (∆<sub>week6-0</sub> − 7.0, IQR − 15.9–8.2 µmol/g feces) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig4\">4</a>C). These observations correspond to previous studies that reported higher overall SCCA in fermented dairy consumers, in particular cheese, compared to non-consumers [<a target=\"_blank\" title=\"González S, et al. Fermented dairy foods: impact on intestinal microbiota and health-linked biomarkers. Front Microbiol. 2019. \n                  https://doi.org/10.3389/fmicb.2019.01046\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR48\">48</a>]. Moreover, changes in fecal levels SCCA profiles were observed in a similar cohort consuming skyr [<a target=\"_blank\" title=\"Ghiamati Yazdi F, et al. Long-term daily high-protein, drained yoghurt consumption alters abundance of selected functional groups of the human gut microbiota and fecal short-chain fatty acid profiles in a cohort of overweight and obese women. J Funct Foods. 2022;93: 105089.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR46\">46</a>], linking the uptake of fermented dairy to intestinal fermentation activity.</p><p>Lactate levels were significantly higher in the skyr (4.8 IQR 3.1–7.6 µmol/g feces, <i>p</i> &lt; 0.05) compared to the control group (3.1 µmol/g feces, IQR 2.6–4.7 µmol/g feces) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig4\">4</a>B) at week 12 as observed before by Yazdi et al. [<a target=\"_blank\" title=\"Ghiamati Yazdi F, et al. Long-term daily high-protein, drained yoghurt consumption alters abundance of selected functional groups of the human gut microbiota and fecal short-chain fatty acid profiles in a cohort of overweight and obese women. J Funct Foods. 2022;93: 105089.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR46\">46</a>]. Fecal lactate could be derived through dietary lactate or because of the higher lactate formation capacity during skyr consumption containing lactose and the starter culture. Valerate levels significantly increased within the skyr group between week 0 (4.7, IQR 4.5–5.3 µmol/g feces) and week 6 (5.2, IQR 4.8–6.4 µmol/g feces, <i>p</i> &lt; 0.05). At the same time, the increase in valerate levels was higher in the skyr group at week 6 (∆<sub>week6-0</sub> 0.5, IQR 0.1–3.2 µmol/g feces) compared to the control (∆<sub>week6-0</sub> 0.1, IQR − 0.5–0.7 µmol/g feces) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Fig4\">4</a>C). After 6 weeks, carriers of <i>Megasphaera</i> that were allocated to daily skyr supplementation produced significantly higher fecal levels of valerate (5.3, IQR 5.2–5.9 µmol/g feces) compared to the control group (5.0, IQR 4.6–5.1 µmol/g feces) (Wilconox test, p &lt; 0.05). Together with the results observed in vitro<i>, </i> our data suggest that the presence of <i>Megasphaera</i> relates to the potential of intestinal microbiota to form valerate after the uptake of lactose/lactate containing fermented dairy. Higher fecal valerate were also observed after consumption of fermented vegetables [<a target=\"_blank\" title=\"Guse K, et al. Regular consumption of lacto-fermented vegetables has greater effects on the gut metabolome compared with the microbiome. Gut Microbiome. 2023;4: e11.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR49\">49</a>], which indicates a general potential to modulate valerate levels with the consumption of lactate-containing fermented food.</p><h3 id=\"Sec11\">Microbiota composition relates to the presence of <i>Megasphaera</i>\n                        </h3><p>Cross-feeding activity of <i>Megasphaera</i> relies on the presence of functional groups delivering lactate. We performed linear discriminant analysis (LDA) [<a target=\"_blank\" title=\"Xu S, et al. MicrobiotaProcess: a comprehensive R package for deep mining microbiome. Innov Camb Mass. 2023;4: 100388.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR50\">50</a>] using the relative abundance data to identify taxa that distinguish between microbial community profiles that harbored or did not possess <i>Megasphaera</i>. We used results obtained by qPCR to classify microbial communities as <i>Megasphaera</i> positive or negative, and included 16S rRNA gene amplicon sequencing data sets collected after 48 h batch fermentation (in vitro) and from feces collected from the cohort data all three time-points (in vivo). Only LDA scores above 2 were considered relevant [<a target=\"_blank\" title=\"Harakeh S, et al. Impact of smoking cessation, coffee and bread consumption on the intestinal microbial composition among Saudis: a cross-sectional study. PLoS One. 2020;15: e0230895.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR51\">51</a>].</p><p>LDA analysis identified <i>Negativicutes</i>/<i>Veillionellaceae</i>/<i>Megasphaera</i> as discriminatory taxa (<i>p</i> &lt; 0.01) between <i>Megasphaera-</i>positive and -negative microbiota in vitro and in vivo validating our initial classification (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Tab3\">3</a>). <i>Lactobacillaceae</i>/<i>Lactobacillus</i> were enriched (<i>p</i> &lt; 0.01) in <i>Megasphaera</i>-positive microbiota (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Tab3\">3</a>) possibly because <i>Megasphaera</i> possibly benefits from a commensal relationship [<a target=\"_blank\" title=\"Culp EJ, Goodman AL. Cross-feeding in the gut microbiome: ecology and mechanisms. Cell Host Microbe. 2023;31:485–99.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR3\">3</a>] with the lactate-producers <i>Lactobacillus</i> [<a target=\"_blank\" title=\"Gänzle MG. Lactic metabolism revisited: metabolism of lactic acid bacteria in food fermentations and food spoilage. Curr Opin Food Sci. 2015;2:106–17.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR52\">52</a>]. In pigs, both taxa <i>Megasphaera</i> and <i>Lactobacillus</i> increased in abundance after the consumption of fermented feed [<a target=\"_blank\" title=\"Yoshikawa S, et al. Thermophile-fermented feed modulates the gut microbiota related to lactate metabolism in pigs. J Appl Microbiol. 2024;135: lxae254.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR53\">53</a>], and here we present a relationship for human fecal microbiota. In contrast, members of the order <i>Oscillospirales/Ruminococcaceae/Faecalibacterium</i> (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Tab3\">3</a>) were more prominent in <i>Megasphaera</i>-negative microbiota. The genus <i>Oscillibacter</i> includes the valerate forming species <i>Oscillibacter valericigenes</i> [<a target=\"_blank\" title=\"Iino T, Mori K, Tanaka K, Suzuki K, Harayama S. Oscillibacter valericigenes gen. nov., sp. nov., a valerate-producing anaerobic bacterium isolated from the alimentary canal of a Japanese corbicula clam. Int J Syst Evol Microbiol. 2007;57:1840–5.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR54\">54</a>], and in vitro, <i>Oscillibacter</i> was indicative of <i>Megasphaera-</i>negative microbiota (<i>p</i> &lt; 0.01) (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Tab3\">3</a>), possibly as an alternative taxon with the ability to produce valerate. In addition, the <i>A. hallii</i> group and <i>Anaerostipes</i> spp. were more prominent in <i>Megasphaera</i>-negative microbiota. Both groups contain members that produce butyrate from lactate [<a target=\"_blank\" title=\"Louis P, Duncan SH, Sheridan PO, Walker AW, Flint HJ. Microbial lactate utilisation and the stability of the gut microbiome. Gut Microbiome. 2022;3: e3.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR4\">4</a>], indicating that competition for lactate can shape the microbial community (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#Tab3\">3</a>).\n</p><div><figure><figcaption><b>Table 3 Taxa co-occurring with <i>Megasphaera</i>. Based on the presence of <i>Megasphaera</i> that was determined by qPCR of <i>M. elsdenii</i> and <i>M. massiliensis</i>, microbiota was classified as <i>Megasphaera-positive</i> or <i>Megasphaera-negative</i>. Linear discriminant analysis (LDA) score between <i>Megasphaera-</i>positive or <i>-</i>negative was calculated using 16S rRNA gene Libraries from in vitro experiments after 48 h incubation and from cohort data at all time points. N.A. no LDA score available</b></figcaption><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6/tables/3\"><span>Full size table</span></a></p></figure></div><p>Taken together, we observed the co-occurrence of <i>Megasphaera</i> with the lactate-producing genus <i>Lactobacillus</i> which can indicate a relevant cross-feeding scheme in the gut. Moreover, <i>Megasphaera</i> presence was linked to decreased abundance of genera related to lactate consumption, competing for the same substrate.</p></div></div><div><h2 id=\"Sec12\">Conclusion</h2><p>Our study identified <i>Megasphaera</i> as a taxon that only occurred in about 20–30% of adults and often at low abundance. Using an integrative and targeted experimental approach including in vitro assays and fecal microbial community modulation with lactose/lactate and <i>Megasphaera</i>, we provide mechanistic understanding on the contribution of <i>Megasphaera</i> to lactate-dependent cross-feeding in vitro. In vitro and in vivo in a free-living cohort of overweight/obese women that consumed fermented dairy, valerate levels increased significantly after lactose supplementation to fecal microbiota or daily lactose/lactate containing skyr consumption for 6 weeks, respectively. These observations indicate the potential of <i>Megasphaera</i> to respond to dietary lactose/lactate. We identified co-occurrence pattern of <i>Megasphaera</i> with the lactate-producing genus <i>Lactobacillus</i>, and possible competition with other lactate-utilizers. Together, our data attributes <i>Megasphaera</i> a pivotal role in fulfilling a specific function related to the uptake of fermented dairy in the host.</p></div><div><h2 id=\"Sec13\">Materials and methods</h2><div><h3 id=\"Sec14\">Strains and cultivation conditions</h3><p><i>S. thermophilus</i> LMG 18311 was donated by Daniel Straume, Norwegian University of Life Sciences, Ås, Norway, and was originally isolated from a commercial yogurt. <i>M. elsdenii</i> DMS 20460 was purchased from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany).</p><p><i>S. thermophilus</i> was routinely cultured using Todd-Hewitt glucose medium (THG) containing 3.7% (w/v) Todd-Hewitt powder and 44.4 mM glucose, or TH that was supplemented with lactose (THL, 10 mM). <i>M. elsdenii</i> was cultivated using Wilkin-Chalgren soya peptone medium (WCSP) or WCSP supplemented with lactate (WCSP-Lac, 10 mM). All media ingredients were purchased from Merck, Søborg, Denmark, unless otherwise stated.</p><p>Single and co-culture fermentations were performed in yeast extract casitone medium containing SCCA [<a target=\"_blank\" title=\"Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002;68:5186–90.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR36\">36</a>] and 40 mM lactose (YCFA-L). The composition of the medium per 100 mL was: 1 g of Casitone; 0.25 g of yeast extract; 0.4 g of NaHCO<sub>3</sub>; 0.1 g of cysteine; 0.045 g of K<sub>2</sub>HPO<sub>4</sub>; 0.045 g of KH<sub>2</sub>PO<sub>4</sub>; 0.09 g of NaCl; 0.009 g of MgSO<sub>4</sub> · 7H<sub>2</sub>O; 0.009 g of CaCl<sub>2</sub>; 0.1 mg of resazurin; 1 mg of hemin; and a vitamin solution (MEM, 100x). A stock solution of SCCA was added for final concentrations of 33 mM acetate, 9 mM propionate, 1.2 mM iso-butyrate, 1.0 mM iso-valerate, and 1.0 mM valerate.</p><p>Fecal slurry fermentations were performed using a modified Macfarlane medium with enhanced buffer capacity as described previously [<a target=\"_blank\" title=\"Bircher L, Schwab C, Geirnaert A, Lacroix C. Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology. Microb Biotechnol. 2018;11:163–75.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR55\">55</a>]. This medium was designed to simulate the complex carbohydrate and nitrogen sources available in the large intestine [<a target=\"_blank\" title=\"Macfarlane GT, Macfarlane S, Gibson GR. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol. 1998;35:180–7.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR56\">56</a>] and contained additional SCCA [<a target=\"_blank\" title=\"Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002;68:5186–90.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR36\">36</a>]. The composition of the medium (g/L) in MilliQ water was as follows: 1.0 cellobiose, 1.0 xylan, 1.0 arabinogalactan, 0.5 inulin, 1.0 soluble starch, 3.0 amicase, 5.0 bacto tryptone, 1.5 meat extract, 4.5 yeast extract, 4.0 porcine mucin, 0.005 hemin, 0.4 bile salt, 3.0 KH₂PO₄, 9.0 NaHCO₃, 0.61 MgSO₄, 0.1 CaCl₂·2H₂O, 0.2 MnCl₂·4H₂O, 0.005 FeSO₄·7H₂O, 0.1 ZnSO₄·7H₂O, 4.5 NaCl, and 4.5 KCl. Tween 80 (1 mL) and SCCA were added for final concentrations of 33 mM acetate, 1 mM each of isobutyrate, isovalerate, and valerate, and 9 mM propionate. A proportion of the medium was supplemented with 10 mM lactose (MF-L) or 12.5 mM lactate (MF-Lac).</p><p>All media were prepared anaerobically. Briefly, the pH of the media was adjusted to 7.1 using 3.0 M NaOH, resulting in a final pH of approximately 6.5 after autoclaving. The medium was boiled for 15 min and after cooling, the medium was flushed with CO₂, followed by the addition of 0.5 g/L cysteine-HCl and 0.1 mL/L vitamin solution (MEM, 100x). Aliquots of 10 mL were dispensed into Hungate tubes or 20-mL serum flasks under a CO₂ flow. Tubes and flasks were sealed with butyl rubber stoppers and aluminum caps and autoclaved at 121 °C for 15 min.</p><p>To obtain working cultures, <i>S. thermophilus</i> and <i>M. elsdenii</i> derived from − 80 °C glycerol stocks were grown on THG and WCSP agar plates (1.5%) at 42 and 37 °C, respectively. Single colonies were picked for each individual experiment to obtain working cultures and incubated in WCSP for <i>M. elsdenii</i> or THG for <i>S. thermophilus</i>. After 24 h incubation, cultures were transferred to fresh medium for a 2nd incubation (2% v/v) in THL for <i>S. thermophilus</i> or WCSP-Lac for <i>M. elsdenii</i>. In all experiments, media composition and growth conditions were kept consistent across all experimental replicates. Working cultures were routinely checked under the microscope to ensure purity.</p><p>To perform co-culture assays, working cultures of <i>S. thermophilus</i> or <i>M. elsdenii</i> were inoculated at 1% (v/v) in YCFA-L. For comparison, both strains were also grown alone. Cultures were incubated at 37 °C and turbidity was measured with the McFarland Densitometer (Grant-Bio) at 0, 24, and 48 h of incubation. At the same time points, 1 mL culture was collected and centrifuged at 10,000 g for 4 min. Supernatant were stored at − 20 °C until further analysis. The experiment was run in three independent biological replicates from selected individual colonies. Working cultures were checked routinely under the microscope to ensure purity.</p><h3 id=\"Sec16\">Donor recruitment and fecal sample processing for in vitro batch fermentations</h3><p>Fresh fecal samples for in vitro batch fermentations were collected anonymously from healthy donors in 2023 and 2024. Collection and further processing are exempt from ethical approval according to the National Scientific Committee (National Videnskabsetisks Komite, NVK, Denmark). The donors were between 20 and 51 years old and had eating patterns (at least 3 meals/day, 7 days/week) and bowel movements (once every 3 days to 3 times per day), considered regular [<a target=\"_blank\" title=\"Brenner DM, Corsetti M, Drossman D, Tack J, Wald A. Perceptions, definitions, and therapeutic interventions for occasional constipation: a Rome working group consensus document. Clin Gastroenterol Hepatol. 2024;22:397–412.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR39\">39</a>]. Donors did not take any food supplements containing prebiotics or probiotics nor used any medication affecting the gut transit, blood pressure, and digestion or antibiotics during the last 3 months preceding the sample donation. Additionally, the donors were not taking part in any weight loss diet/change in diet, present any intestinal discomfort, major operative intestinal intervention, or diseases that could affect the gastrointestinal tract (e.g., chronic inflammatory or autoimmune conditions). All donors provided written consent. In total, 20 fecal samples were collected (D1–D20), and samples D1–D10 were also used in the study of Li et al. [<a target=\"_blank\" title=\"Li Q. et al. In vitro investigations on the impact of fermented dairy constituents on fecal microbiota composition and fermentation activity (manuscript accepted). Microbiol. Spectr. 2025;13(3):e02193-24. \n                  https://doi.org/10.1128/spectrum.02193-24\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR33\">33</a>].</p><p>Each fecal sample was immediately transferred to a sealed bag containing an anaerobic gas pack (BD) and was processed within 12 h of defecation. To prepare fecal slurries, all work was conducted in an anaerobic bench (Baker Ruskinn) to keep a strict anaerobic environment. Approximately 1 g of fresh fecal sample was added to a Hungate tube containing 10 mL anaerobically prepared peptone water (0.1% (m/v)). The samples were vortexed for 5 min to create a homogenous mixture. In vitro batch fermentations were initiated with freshly prepared fecal slurries as inoculum (1% (v/v)) using MF-C, MF-L, and MF-Lac; and another condition for which MF-L was additionally supplied with 1% working culture <i>M. elsdenii</i> (MF-L + M). Fermentations were run in single cultures or duplicates as indicates (Fig. 2A), for duplicates average values are presented. Flasks were placed in a shaking incubator at 140 r/m and 37 °C. Samples were collected after 0, 24, and 48 h of fermentation for further analyses and pH was recorded after 48 h. Supernatant and biomass from 1 mL sample were separated by centrifugation at 10,000 rpm for 10 min and stored at − 20 °C for analysis of fermentation metabolites and DNA isolation, respectively.</p><h3 id=\"Sec17\">Microbiota analysis using 16S rRNA gene amplicon sequencing</h3><p>DNA was isolated from the in vitro fecal slurry samples and from fecal samples collected from the cohort employing FastDNA Spin Kit for soil (MP Biomedicals). DNA was not isolated from the fermentation of D3 due to a lack of biomass. Microbiota profiling was conducted using 16S rRNA gene amplicon sequencing, following a two-step PCR method based on Illumina’s 16S Metagenomic Sequencing Library Preparation protocol as previously reported [<a target=\"_blank\" title=\"Høgsgaard K, et al. Fucose modifies short chain fatty acid and H2S formation through alterations of microbial cross-feeding activities. FEMS Microbiol Ecol. 2023;99: fiad107.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR40\">40</a>]. Briefly, the V3–V4 hypervariable region of the 16S rRNA gene amplicon sequencing was amplified using primers Bac341F (5′- TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG CCT ACG GGN GGC WGC AG-3′) and Bac805R (5′- GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GGA CTA CHV GGG TAT CTA ATC C-3′) with adapters. The PCR mix consisted of 12.5 μL of 2 × KAPA HiFi HotStart readyMix (Roche), 0.5 μL each of forward and reverse primers, 1 μL DNA template, and 10.5 μL nuclease-free water. The initial PCR included 25 cycles of denaturation at 95 °C for 30 s, annealing at 55 °C for 30 s, and extension at 72 °C for 30 s, followed by a final extension at 72 °C for 5 min. A second PCR, using primers with barcodes, was performed for 8 additional cycles. The amplicons were purified using Ampure XP beads (Beckman Coulter, Denmark), and sequencing was carried out on a MiSeq sequencer (Illumina) at the Section of Microbiology, Aarhus University, according to standard Illumina protocols. Each run included negative control from a mock DNA isolation.</p><p>To process the reads, primer sequences were removed using cutadapt (v4.2) with the following parameters: -O 12 –discard-untrimmed -g CCTACGGGNGGCWGCAG -G GACTACHVGGGTATCTAATCC –pair-adapters –minimum-length 75 [<a target=\"_blank\" title=\"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal. 2011;17:10–2.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR57\">57</a>]. Only reads containing both primers and at least 75 bases were retained for downstream analysis. Quality filtering of reads was performed using the filterAndTrim function of the dada2 package, with parameters set to maxEE = 2, truncQ = 3, minLen = 150, trimRight = 40, and trimLeft = 40. Sample inference was conducted using the learnErrors and dada functions, with the pool = pseudo parameter [<a target=\"_blank\" title=\"Callahan BJ, et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–3.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR58\">58</a>]. Paired reads were merged using mergePairs, and chimeras were removed using removeBimeraDenovo (method = pooled). The resulting amplicon sequence variants (ASV) were taxonomically classified with the IDTAXA classifier [<a target=\"_blank\" title=\"Murali A, Bhargava A, Wright ES. IDTAXA: a novel approach for accurate taxonomic classification of microbiome sequences. Microbiome. 2018;6: 140.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR59\">59</a>] against the Silva SSU v138 database [<a target=\"_blank\" title=\"Quast C, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590–6.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR60\">60</a>].</p><h3 id=\"Sec18\">qPCR of members of the <i>Megasphaera</i> genus</h3><p>The abundance <i>M. massiliensis</i> and <i>M. elsdenii</i> was determined using qPCR targeting the 16S rRNA gene. Primers targeting <i>M. massiliensis</i> were designed based on 16S rRNA gene amplicon sequences libraries derived in this study, and primers for <i>M. elsdenii</i> were obtained from a previous study [<a target=\"_blank\" title=\"Stevenson DM, Weimer PJ. Dominance of Prevotella and low abundance of classical ruminal bacterial species in the bovine rumen revealed by relative quantification real-time PCR. Appl Microbiol Biotechnol. 2007;75:165–74.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR61\">61</a>]. Standard curves were generated using Linearized plasmids containing fragments of 16S rRNA gene of <i>M. elsdenii</i> type strain DSM 20460 or from <i>M. massiliensis</i> positive donors (Suppl. Table 1).</p><p>The qPCR master mix comprised 5 μL iTag Universal 2 × SYBR Green Supermix (Bio-Rad), 1 μL forward and reverse primer (Suppl. Table 1), 2 μL nuclease-free water, and 1 μL of diluted DNA, totalling 10 μL per reaction in a 96-well (low profile clear/clear) PCR plate, sealed with Microseal “B” Sealing film (both Bio-Rad). Each sample was run in duplicate, and each run included a standard and a negative control (nuclease-free water). Reactions were performed using a CFX Connect Real Time PCR system (Bio-Rad) as follows: hot-start activation at 95 °C for 3 min, followed by 40 cycles of denaturation at 95 °C for 10 s, annealing at 60 °C for 30 s, and melting curve analysis. Absolute cell abundance was determined accounting for multiple 16S rRNA gene amplicon copies of <i>Megasphaera</i> (<i>n</i> = 7) [<a target=\"_blank\" title=\"Stoddard SF, Smith BJ, Hein R, Roller BRK, Schmidt TM. RrnDB: improved tools for interpreting rRNA gene abundance in bacteria and archaea and a new foundation for future development. Nucleic Acids Res. 2015;43:D593-598.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR62\">62</a>] (Suppl. Table 1).</p><h3 id=\"Sec19\">Cohort and dietary analysis</h3><p>Details of the cohort have been described previously [<a target=\"_blank\" title=\"Correia BSB, Dalgaard LB, Thams L, Hansen M, Bertram HC. Changes in the urinary metabolome accompanied alterations in body mass and composition in women with overweight – impact of high versus low protein breakfast. Metabolomics. 2024;20: 81.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR35\">35</a>, <a target=\"_blank\" title=\"Dalgaard LB, et al. No effects of high versus low protein breakfast on body composition and cardiometabolic health in young women with overweight - the NewStart randomized trial. Br J Nutr. 2014;1–30. \n                  https://doi.org/10.1017/S0007114524003015\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR63\">63</a>]. Briefly, a total of 75 overweight or obese women (BMI &gt; 25 kg/m<sup>2</sup>) were allocated to consume either a fermented dairy-based drained yogurt, high-protein breakfast (skyr), or a bread-based low-protein breakfast (control) [<a target=\"_blank\" title=\"Correia BSB, Dalgaard LB, Thams L, Hansen M, Bertram HC. Changes in the urinary metabolome accompanied alterations in body mass and composition in women with overweight – impact of high versus low protein breakfast. Metabolomics. 2024;20: 81.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR35\">35</a>, <a target=\"_blank\" title=\"Dalgaard LB, et al. No effects of high versus low protein breakfast on body composition and cardiometabolic health in young women with overweight - the NewStart randomized trial. Br J Nutr. 2014;1–30. \n                  https://doi.org/10.1017/S0007114524003015\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR63\">63</a>]. The meals were isocaloric. The fermented dairy-based meal consisted of drained yogurt with oats and 150 mL of water, while the control meal consisted of a whole-grain toast with jam and 150 mL of juice. The supplementation study lasted 12 weeks with fecal sample collections at week 0, week 6, and week 12 [<a target=\"_blank\" title=\"Dalgaard LB, et al. No effects of high versus low protein breakfast on body composition and cardiometabolic health in young women with overweight - the NewStart randomized trial. Br J Nutr. 2014;1–30. \n                  https://doi.org/10.1017/S0007114524003015\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR63\">63</a>]. In our study, only participants that provided three fecal samples were included (<i>n</i> = 49, 21 in the skyr and 28 in the control groups). Fecal samples were stored at − 80 °C until further use. Dietary records were collected at baseline and at the end of the study. In a food frequency questionnaire, participants were asked whether they had consumed dairy products such as yogurt, drained yogurt (skyr), sour milk with <i>Lactobacillus acidophilus</i> cultures, drinking yogurt, or similar products in the past month (yes/no answer). Additionally, participants were asked whether they had consumed milk (containing lactose) and/or fermented dairy products (containing lactose and/or lactate); participants who consumed milk were classified as “milk consumers,” while participants that consumed any type of fermented dairy including the skyr group were considered “fermented dairy consumers.” “Dairy consumers” included individuals who consumed both milk and fermented dairy. </p><h3 id=\"Sec20\">Substrate and metabolite analysis</h3><p>For the extraction of fermentation metabolites from fecal samples, 200–300 mg of material was mixed with 1 mL 5 mM H₂SO₄, vortexed, and centrifuged at 10,000 rpm for 10 min. Supernatants from in vitro batch fermentation samples were obtained by centrifugation at 10,000 rpm for 4 min. All samples were filtered through a 0.45-μm polytetrafluoroethylene (PTFE) membrane filter prior to analysis. A dilution 1:3 was used for the fecal samples. Concentrations of SCCA (acetate, propionate, butyrate, lactate, succinate, and valerate) and of lactose, glucose, and galactose in fecal and fermentation samples were analyzed by HPLC-RI using an Agilent 1260 Infinity II LC system equipped with a refractive index detector (RID) and an Hi-Plex H column (300 × 7.7 mm) coupled with a guard column (50 × 7.7 mm). Samples were injected (10 μL), and compound were eluted using 5 mM H₂SO₄ at a flow rate of 0.6 mL/min at 40 °C. Quantification of fermentation metabolites was carried out using external standards.</p><h3 id=\"Sec21\">Statistical analysis</h3><p>For analysis of the 16S rRNA amplicon gene sequencing libraries, α-diversity was calculated using the microbiome package [<a target=\"_blank\" title=\"Lahti L, Shetty S (2012–2019). “microbiome R package.” Version 1.23.1. URL: \n                  http://microbiome.github.com/microbiome\n                , Bioconductor.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR64\">64</a>]. 16S rRNA reads were pruned and rarefied prior to use. In slurry, data pruning did not remove any taxa while for the cohort 267 taxa were removed. From cohort, a total of 1520 OTUs were removed after rarefication by depth while 208 OTUs were removed for the slurry data. Counts were used to calculate the richness and diversity indices (Chao1, Shannon, Evenness, and InverseSimpson) in RStudio. Since data was not normally distributed, Kruskal–Wallis and Dunn’s test were used to estimate differences of alpha diversity indices between diets [<a target=\"_blank\" title=\"Kassambara A. rstatix: pipe-friendly framework for basic statistical tests. 2023. \n                  https://github.com/kassambara/rstatix\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR65\">65</a>]. Beta-diversity was calculated using Bray–Curtis dissimilarity matrix implemented in the R package MicrobiotaProcess [<a target=\"_blank\" title=\"Xu S, et al. MicrobiotaProcess: a comprehensive R package for deep mining microbiome. Innov Camb Mass. 2023;4: 100388.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR50\">50</a>]. Principal coordinate analysis (PCoA) ordination was used for visualization. “Adonis2” was used to identify differences between diet and/or time using PERMANOVA [<a target=\"_blank\" title=\"Oksanen J, et al. vegan: community ecology package. 2024. \n                  https://vegandevs.r-universe.dev/vegan\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR66\">66</a>]. Correlation analysis between the relative abundance of the 25 most abundant genera and fermentation metabolites was performed with “rstatix” [<a target=\"_blank\" title=\"Kassambara A. rstatix: pipe-friendly framework for basic statistical tests. 2023. \n                  https://github.com/kassambara/rstatix\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR65\">65</a>] package using Spearman correlation test. For linear discriminant analysis (LDA), we used the package MicrobiotaProcess [<a target=\"_blank\" title=\"Xu S, et al. MicrobiotaProcess: a comprehensive R package for deep mining microbiome. Innov Camb Mass. 2023;4: 100388.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR50\">50</a>] with the following setting: initial Kruskal–Wallis test with a <i>p</i>-value filtration of 0.05 and a second Wilcox test with a <i>p</i>-value filtration of 0.01. We included 16S rRNA gene amplicon sequence Libraries from all collection points of the cohort, and from 48 h incubation of the in vitro fecal microbiota batch fermentations. The LDA score that was considered significant was LDA &gt; 2 [<a target=\"_blank\" title=\"Xu S, et al. MicrobiotaProcess: a comprehensive R package for deep mining microbiome. Innov Camb Mass. 2023;4: 100388.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR50\">50</a>].</p><p>To compare fecal levels of fermentation metabolites and the relative abundance of bacterial groups at different time points and in in vitro fecal fermentations, we used Kruskal–Wallis and Dunn’s test [<a target=\"_blank\" title=\"Kassambara A. rstatix: pipe-friendly framework for basic statistical tests. 2023. \n                  https://github.com/kassambara/rstatix\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR65\">65</a>]. Changes in concentration of fecal fermentation metabolites or relative abundance within an study group over time were evaluated using the Friedman test adjusted by post hoc Wilcox paired test [<a target=\"_blank\" title=\"Kassambara A. rstatix: pipe-friendly framework for basic statistical tests. 2023. \n                  https://github.com/kassambara/rstatix\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02207-6#ref-CR65\">65</a>].</p></div></div>\n                                </div><div><h2 id=\"Bib1\">References</h2><div><ol><li><p>Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14: e1002533.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1371%2Fjournal.pbio.1002533\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27541692\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991899\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Revised%20estimates%20for%20the%20number%20of%20human%20and%20bacteria%20cells%20in%20the%20body&amp;journal=PLoS%20Biol&amp;doi=10.1371%2Fjournal.pbio.1002533&amp;volume=14&amp;publication_year=2016&amp;author=Sender%2CR&amp;author=Fuchs%2CS&amp;author=Milo%2CR\">\n                    Google Scholar</a> \n                </p></li><li><p>Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165:1332–45.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cell.2016.05.041\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27259147\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC28Xpslaltro%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=From%20dietary%20fiber%20to%20host%20physiology%3A%20short-chain%20fatty%20acids%20as%20key%20bacterial%20metabolites&amp;journal=Cell&amp;doi=10.1016%2Fj.cell.2016.05.041&amp;volume=165&amp;pages=1332-1345&amp;publication_year=2016&amp;author=Koh%2CA&amp;author=Vadder%2CF&amp;author=Kovatcheva-Datchary%2CP&amp;author=B%C3%A4ckhed%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>Culp EJ, Goodman AL. Cross-feeding in the gut microbiome: ecology and mechanisms. Cell Host Microbe. 2023;31:485–99.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.chom.2023.03.016\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37054671\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125260\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXnslarsr8%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Cross-feeding%20in%20the%20gut%20microbiome%3A%20ecology%20and%20mechanisms&amp;journal=Cell%20Host%20Microbe&amp;doi=10.1016%2Fj.chom.2023.03.016&amp;volume=31&amp;pages=485-499&amp;publication_year=2023&amp;author=Culp%2CEJ&amp;author=Goodman%2CAL\">\n                    Google Scholar</a> \n                </p></li><li><p>Louis P, Duncan SH, Sheridan PO, Walker AW, Flint HJ. Microbial lactate utilisation and the stability of the gut microbiome. Gut Microbiome. 2022;3: e3.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1017%2Fgmb.2022.3\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39295779\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406415\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Microbial%20lactate%20utilisation%20and%20the%20stability%20of%20the%20gut%20microbiome&amp;journal=Gut%20Microbiome&amp;doi=10.1017%2Fgmb.2022.3&amp;volume=3&amp;publication_year=2022&amp;author=Louis%2CP&amp;author=Duncan%2CSH&amp;author=Sheridan%2CPO&amp;author=Walker%2CAW&amp;author=Flint%2CHJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Reichardt N, et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 2014;8:1323–35.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fismej.2014.14\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24553467\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030238\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXosVyqt74%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Phylogenetic%20distribution%20of%20three%20pathways%20for%20propionate%20production%20within%20the%20human%20gut%20microbiota&amp;journal=ISME%20J&amp;doi=10.1038%2Fismej.2014.14&amp;volume=8&amp;pages=1323-1335&amp;publication_year=2014&amp;author=Reichardt%2CN\">\n                    Google Scholar</a> \n                </p></li><li><p>Elvan Gezer M, et al. Investigation on L-rhamnose metabolism of Loigolactobacillus coryniformis subsp. coryniformis DSM 20001 and its propionate-containing fermentates. Appl Environ Microbiol. 2024;91:e01613-24.</p><p><a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39692501\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11784251\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Investigation%20on%20L-rhamnose%20metabolism%20of%20Loigolactobacillus%20coryniformis%20subsp.%20coryniformis%20DSM%2020001%20and%20its%20propionate-containing%20fermentates&amp;journal=Appl%20Environ%20Microbiol.&amp;volume=91&amp;pages=e01613-24&amp;publication_year=2024&amp;author=Elvan%20Gezer%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19:29–41.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1111%2F1462-2920.13589\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27928878\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhsFagu78%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Formation%20of%20propionate%20and%20butyrate%20by%20the%20human%20colonic%20microbiota&amp;journal=Environ%20Microbiol&amp;doi=10.1111%2F1462-2920.13589&amp;volume=19&amp;pages=29-41&amp;publication_year=2017&amp;author=Louis%2CP&amp;author=Flint%2CHJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Wells JM, et al. Homeostasis of the gut barrier and potential biomarkers. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2017;312:G171–93.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1152%2Fajpgi.00048.2015\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27908847\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Homeostasis%20of%20the%20gut%20barrier%20and%20potential%20biomarkers&amp;journal=American%20Journal%20of%20Physiology-Gastrointestinal%20and%20Liver%20Physiology&amp;doi=10.1152%2Fajpgi.00048.2015&amp;volume=312&amp;pages=G171-G193&amp;publication_year=2017&amp;author=Wells%2CJM\">\n                    Google Scholar</a> \n                </p></li><li><p>Wang J, Yin Y. Biological production of medium-chain carboxylates through chain elongation: an overview. Biotechnol Adv. 2022;55: 107882.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.biotechadv.2021.107882\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34871718\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xpsl2rsrk%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Biological%20production%20of%20medium-chain%20carboxylates%20through%20chain%20elongation%3A%20an%20overview&amp;journal=Biotechnol%20Adv&amp;doi=10.1016%2Fj.biotechadv.2021.107882&amp;volume=55&amp;publication_year=2022&amp;author=Wang%2CJ&amp;author=Yin%2CY\">\n                    Google Scholar</a> \n                </p></li><li><p>de Smit SM, de Leeuw KD, Buisman CJN, Strik DPBTB. Continuous n-valerate formation from propionate and methanol in an anaerobic chain elongation open-culture bioreactor. Biotechnol Biofuels. 2019;12:132.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1186/s13068-019-1468-x\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31149028\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535856\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Continuous%20n-valerate%20formation%20from%20propionate%20and%20methanol%20in%20an%20anaerobic%20chain%20elongation%20open-culture%20bioreactor&amp;journal=Biotechnol%20Biofuels&amp;doi=10.1186%2Fs13068-019-1468-x&amp;volume=12&amp;publication_year=2019&amp;author=Smit%2CSM&amp;author=Leeuw%2CKD&amp;author=Buisman%2CCJN&amp;author=Strik%2CDPBTB\">\n                    Google Scholar</a> \n                </p></li><li><p>Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol. 2004;70:5810–7.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1128%2FAEM.70.10.5810-5817.2004\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15466518\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC522113\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2cXosl2itb8%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Lactate-utilizing%20bacteria%2C%20isolated%20from%20human%20feces%2C%20that%20produce%20butyrate%20as%20a%20major%20fermentation%20product&amp;journal=Appl%20Environ%20Microbiol&amp;doi=10.1128%2FAEM.70.10.5810-5817.2004&amp;volume=70&amp;pages=5810-5817&amp;publication_year=2004&amp;author=Duncan%2CSH&amp;author=Louis%2CP&amp;author=Flint%2CHJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Barker HA. Pathway of 5-aminovalerate degradation by <i>Clostridium aminovalericum</i>. in <i>Current Topics in Cellular Regulation</i> (eds. Levine, R. L. &amp; Ginsburg, A.) vol. 26 349–354 (Academic Press, 1985).</p></li><li><p>McDonald JAK, et al. Inhibiting growth of Clostridioides difficile by restoring valerate, produced by the intestinal microbiota. Gastroenterology. 2018;155:1495-1507.e15.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1053%2Fj.gastro.2018.07.014\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30025704\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXitV2qtb%2FK\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Inhibiting%20growth%20of%20Clostridioides%20difficile%20by%20restoring%20valerate%2C%20produced%20by%20the%20intestinal%20microbiota&amp;journal=Gastroenterology&amp;doi=10.1053%2Fj.gastro.2018.07.014&amp;volume=155&amp;pages=1495-1507.e15&amp;publication_year=2018&amp;author=McDonald%2CJAK\">\n                    Google Scholar</a> \n                </p></li><li><p>Martinez-Gili L, et al. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites. Gut Microbes. 2020;12:1810531.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1080%2F19490976.2020.1810531\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32893721\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524310\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Understanding%20the%20mechanisms%20of%20efficacy%20of%20fecal%20microbiota%20transplant%20in%20treating%20recurrent%20Clostridioides%20difficile%20infection%20and%20beyond%3A%20the%20contribution%20of%20gut%20microbial-derived%20metabolites&amp;journal=Gut%20Microbes&amp;doi=10.1080%2F19490976.2020.1810531&amp;volume=12&amp;publication_year=2020&amp;author=Martinez-Gili%2CL\">\n                    Google Scholar</a> \n                </p></li><li><p>Zhai S, et al. <i>Weizmannia coagulans</i> BC99 affects valeric acid production via regulating gut microbiota to ameliorate inflammation and oxidative stress responses in <i>Helicobacter pylori</i> mice. J Food Sci. 2024;89:9985–10002.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1111%2F1750-3841.17514\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39556495\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB2cXisFyjtb%2FJ\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Weizmannia%20coagulans%20BC99%20affects%20valeric%20acid%20production%20via%20regulating%20gut%20microbiota%20to%20ameliorate%20inflammation%20and%20oxidative%20stress%20responses%20in%20Helicobacter%20pylori%20mice&amp;journal=J%20Food%20Sci&amp;doi=10.1111%2F1750-3841.17514&amp;volume=89&amp;pages=9985-10002&amp;publication_year=2024&amp;author=Zhai%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Liu M, et al. Revisiting the role of valeric acid in manipulating ulcerative colitis. Inflamm Bowel Dis. 2024;30:617–28.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fibd%2Fizad187\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=38206334\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Revisiting%20the%20role%20of%20valeric%20acid%20in%20manipulating%20ulcerative%20colitis&amp;journal=Inflamm%20Bowel%20Dis&amp;doi=10.1093%2Fibd%2Fizad187&amp;volume=30&amp;pages=617-28&amp;publication_year=2024&amp;author=Liu%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Sandin A, Bråbäck L, Norin E, Björkstén B. Faecal short chain fatty acid pattern and allergy in early childhood. Acta Paediatr. 2009;98:823–7.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1111%2Fj.1651-2227.2008.01215.x\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19173682\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Faecal%20short%20chain%20fatty%20acid%20pattern%20and%20allergy%20in%20early%20childhood&amp;journal=Acta%20Paediatr&amp;doi=10.1111%2Fj.1651-2227.2008.01215.x&amp;volume=98&amp;pages=823-827&amp;publication_year=2009&amp;author=Sandin%2CA&amp;author=Br%C3%A5b%C3%A4ck%2CL&amp;author=Norin%2CE&amp;author=Bj%C3%B6rkst%C3%A9n%2CB\">\n                    Google Scholar</a> \n                </p></li><li><p>Shuai M, et al. Multi-omics analyses reveal relationships among dairy consumption, gut microbiota and cardiometabolic health. eBioMedicine. 2021. <a target=\"_blank\" href=\"https://doi.org/10.1016/j.ebiom.2021.103284\">https://doi.org/10.1016/j.ebiom.2021.103284</a>.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.ebiom.2021.103284\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34689086\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530107\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Multi-omics%20analyses%20reveal%20relationships%20among%20dairy%20consumption%2C%20gut%20microbiota%20and%20cardiometabolic%20health&amp;journal=eBioMedicine&amp;doi=10.1016%2Fj.ebiom.2021.103284&amp;publication_year=2021&amp;author=Shuai%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. 2019;7: 91.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1186/s40168-019-0704-8\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31196177\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567490\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Macronutrient%20metabolism%20by%20the%20human%20gut%20microbiome%3A%20major%20fermentation%20by-products%20and%20their%20impact%20on%20host%20health&amp;journal=Microbiome&amp;doi=10.1186%2Fs40168-019-0704-8&amp;volume=7&amp;publication_year=2019&amp;author=Oliphant%2CK&amp;author=Allen-Vercoe%2CE\">\n                    Google Scholar</a> \n                </p></li><li><p>Allegue T, et al. Lactate addition boosts valerate yields in granular mixed culture carbohydrate fermentation. J Environ Chem Eng. 2022;10: 108869.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.jece.2022.108869\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB38XivVCqtLzE\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Lactate%20addition%20boosts%20valerate%20yields%20in%20granular%20mixed%20culture%20carbohydrate%20fermentation&amp;journal=J%20Environ%20Chem%20Eng&amp;doi=10.1016%2Fj.jece.2022.108869&amp;volume=10&amp;publication_year=2022&amp;author=Allegue%2CT\">\n                    Google Scholar</a> \n                </p></li><li><p>Soto-Cruz O, Favela-Torres E, Saucedo-Castañeda G. Modeling of growth, lactate consumption, and volatile fatty acid production by <i>Megasphaera elsdenii</i> cultivated in minimal and complex media. Biotechnol Prog. 2002;18:193–200.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1021%2Fbp010189y\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11934285\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD38Xpt1SqtA%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Modeling%20of%20growth%2C%20lactate%20consumption%2C%20and%20volatile%20fatty%20acid%20production%20by%20Megasphaera%20elsdenii%20cultivated%20in%20minimal%20and%20complex%20media&amp;journal=Biotechnol%20Prog&amp;doi=10.1021%2Fbp010189y&amp;volume=18&amp;pages=193-200&amp;publication_year=2002&amp;author=Soto-Cruz%2CO&amp;author=Favela-Torres%2CE&amp;author=Saucedo-Casta%C3%B1eda%2CG\">\n                    Google Scholar</a> \n                </p></li><li><p>Shetty SA, Marathe NP, Lanjekar V, Ranade D, Shouche YS. Comparative genome analysis of <i>Megasphaera</i> sp. reveals niche specialization and its potential role in the human gut. PLoS One. 2013;8: e79353.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1371%2Fjournal.pone.0079353\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24260205\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832451\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Comparative%20genome%20analysis%20of%20Megasphaera%20sp.%20reveals%20niche%20specialization%20and%20its%20potential%20role%20in%20the%20human%20gut&amp;journal=PLoS%20One&amp;doi=10.1371%2Fjournal.pone.0079353&amp;volume=8&amp;publication_year=2013&amp;author=Shetty%2CSA&amp;author=Marathe%2CNP&amp;author=Lanjekar%2CV&amp;author=Ranade%2CD&amp;author=Shouche%2CYS\">\n                    Google Scholar</a> \n                </p></li><li><p>Marounek M, Fliegrova K, Bartos S. Metabolism and some characteristics of ruminal strains of <i>Megasphaera elsdenii</i>. Appl Environ Microbiol. 1989;55:1570–3.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1128%2Faem.55.6.1570-1573.1989\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2764566\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC202906\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DyaL1MXktlKgtLs%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Metabolism%20and%20some%20characteristics%20of%20ruminal%20strains%20of%20Megasphaera%20elsdenii&amp;journal=Appl%20Environ%20Microbiol&amp;doi=10.1128%2Faem.55.6.1570-1573.1989&amp;volume=55&amp;pages=1570-1573&amp;publication_year=1989&amp;author=Marounek%2CM&amp;author=Fliegrova%2CK&amp;author=Bartos%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Yoshikawa S, et al. Valerate production by <i>Megasphaera elsdenii</i> isolated from pig feces. J Biosci Bioeng. 2018;125:519–24.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.jbiosc.2017.12.016\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29331526\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXitlShug%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Valerate%20production%20by%20Megasphaera%20elsdenii%20isolated%20from%20pig%20feces&amp;journal=J%20Biosci%20Bioeng&amp;doi=10.1016%2Fj.jbiosc.2017.12.016&amp;volume=125&amp;pages=519-24&amp;publication_year=2018&amp;author=Yoshikawa%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Zebeli Q, et al. Intraruminal administration of <i>Megasphaera elsdenii</i> modulated rumen fermentation profile in mid-lactation dairy cows. J Dairy Res. 2012;79:16–25.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1017%2FS0022029911000707\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22008515\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC38Xms1Sku78%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Intraruminal%20administration%20of%20Megasphaera%20elsdenii%20modulated%20rumen%20fermentation%20profile%20in%20mid-lactation%20dairy%20cows&amp;journal=J%20Dairy%20Res&amp;doi=10.1017%2FS0022029911000707&amp;volume=79&amp;pages=16-25&amp;publication_year=2012&amp;author=Zebeli%2CQ\">\n                    Google Scholar</a> \n                </p></li><li><p>Yuille S, Reichardt N, Panda S, Dunbar H, Mulder IE. Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid. PLoS One. 2018;13:e0201073.</p></li><li><p>Kim H, Jeon BS, Sang B-I. An efficient new process for the selective production of odd-chain carboxylic acids by simple carbon elongation using <i>Megasphaera hexanoica</i>. Sci Rep. 2019;9: 11999.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41598-019-48591-6\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31427713\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700076\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=An%20efficient%20new%20process%20for%20the%20selective%20production%20of%20odd-chain%20carboxylic%20acids%20by%20simple%20carbon%20elongation%20using%20Megasphaera%20hexanoica&amp;journal=Sci%20Rep&amp;doi=10.1038%2Fs41598-019-48591-6&amp;volume=9&amp;publication_year=2019&amp;author=Kim%2CH&amp;author=Jeon%2CBS&amp;author=Sang%2CB-I\">\n                    Google Scholar</a> \n                </p></li><li><p>Sugihara PT, Sutter VL, Attebery HR, Bricknell KS, Finegold SM. Isolation of <i>Acidaminococcus fermentans</i> and <i>Megasphaera elsdenii</i> from normal human feces. Appl Microbiol. 1974;27:274–5.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1128%2Fam.27.1.274-275.1974\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4589136\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC380007\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:STN:280:DyaE2c%2Fns1Oisg%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Isolation%20of%20Acidaminococcus%20fermentans%20and%20Megasphaera%20elsdenii%20from%20normal%20human%20feces&amp;journal=Appl%20Microbiol&amp;doi=10.1128%2Fam.27.1.274-275.1974&amp;volume=27&amp;pages=274-275&amp;publication_year=1974&amp;author=Sugihara%2CPT&amp;author=Sutter%2CVL&amp;author=Attebery%2CHR&amp;author=Bricknell%2CKS&amp;author=Finegold%2CSM\">\n                    Google Scholar</a> \n                </p></li><li><p>Stanton TB, McDowall JS, Rasmussen MA. Diverse tetracycline resistance genotypes of <i>Megasphaera elsdenii</i> strains selectively cultured from swine feces. Appl Environ Microbiol. 2004;70:3754–7.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1128%2FAEM.70.6.3754-3757.2004\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15184185\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC427801\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2cXltFChsrw%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Diverse%20tetracycline%20resistance%20genotypes%20of%20Megasphaera%20elsdenii%20strains%20selectively%20cultured%20from%20swine%20feces&amp;journal=Appl%20Environ%20Microbiol&amp;doi=10.1128%2FAEM.70.6.3754-3757.2004&amp;volume=70&amp;pages=3754-3757&amp;publication_year=2004&amp;author=Stanton%2CTB&amp;author=McDowall%2CJS&amp;author=Rasmussen%2CMA\">\n                    Google Scholar</a> \n                </p></li><li><p>Garrote GL, Abraham AG, Rumbo M. Is lactate an undervalued functional component of fermented food products? Front Microbiol. 2015;6:629.</p><p><a target=\"_blank\" href=\"https://doi.org/10.3389%2Ffmicb.2015.00629\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26150815\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473639\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Is%20lactate%20an%20undervalued%20functional%20component%20of%20fermented%20food%20products%3F&amp;journal=Front%20Microbiol.&amp;doi=10.3389%2Ffmicb.2015.00629&amp;volume=6&amp;publication_year=2015&amp;author=Garrote%2CGL&amp;author=Abraham%2CAG&amp;author=Rumbo%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Gänzle M. The periodic table of fermented foods: limitations and opportunities. Appl Microbiol Biotechnol. 2022;106:2815–26.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1007/s00253-022-11909-y\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35412130\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20periodic%20table%20of%20fermented%20foods%3A%20limitations%20and%20opportunities&amp;journal=Appl%20Microbiol%20Biotechnol&amp;doi=10.1007%2Fs00253-022-11909-y&amp;volume=106&amp;pages=2815-2826&amp;publication_year=2022&amp;author=G%C3%A4nzle%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Gänzle MG, et al. Starter culture development and innovation for novel fermented foods. Annu Rev Food Sci Technol. 2024;15:211–39.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1146%2Fannurev-food-072023-034207\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=38052450\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Starter%20culture%20development%20and%20innovation%20for%20novel%20fermented%20foods&amp;journal=Annu%20Rev%20Food%20Sci%20Technol&amp;doi=10.1146%2Fannurev-food-072023-034207&amp;volume=15&amp;pages=211-239&amp;publication_year=2024&amp;author=G%C3%A4nzle%2CMG\">\n                    Google Scholar</a> \n                </p></li><li><p>Li Q. et al. In vitro investigations on the impact of fermented dairy constituents on fecal microbiota composition and fermentation activity (manuscript accepted). Microbiol. Spectr. 2025;13(3):e02193-24. <a target=\"_blank\" href=\"https://doi.org/10.1128/spectrum.02193-24\">https://doi.org/10.1128/spectrum.02193-24</a>.</p></li><li><p>Pasolli E, et al. Large-scale genome-wide analysis links lactic acid bacteria from food with the gut microbiome. Nat Commun. 2020;11: 2610.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41467-020-16438-8\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32451391\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248083\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtVCmtrvI\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Large-scale%20genome-wide%20analysis%20links%20lactic%20acid%20bacteria%20from%20food%20with%20the%20gut%20microbiome&amp;journal=Nat%20Commun&amp;doi=10.1038%2Fs41467-020-16438-8&amp;volume=11&amp;publication_year=2020&amp;author=Pasolli%2CE\">\n                    Google Scholar</a> \n                </p></li><li><p>Correia BSB, Dalgaard LB, Thams L, Hansen M, Bertram HC. Changes in the urinary metabolome accompanied alterations in body mass and composition in women with overweight – impact of high versus low protein breakfast. Metabolomics. 2024;20: 81.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1007/s11306-024-02156-5\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39066839\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11283391\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB2cXhs1eksr3O\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Changes%20in%20the%20urinary%20metabolome%20accompanied%20alterations%20in%20body%20mass%20and%20composition%20in%20women%20with%20overweight%20%E2%80%93%20impact%20of%20high%20versus%20low%20protein%20breakfast&amp;journal=Metabolomics&amp;doi=10.1007%2Fs11306-024-02156-5&amp;volume=20&amp;publication_year=2024&amp;author=Correia%2CBSB&amp;author=Dalgaard%2CLB&amp;author=Thams%2CL&amp;author=Hansen%2CM&amp;author=Bertram%2CHC\">\n                    Google Scholar</a> \n                </p></li><li><p>Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002;68:5186–90.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1128%2FAEM.68.10.5186-5190.2002\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12324374\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC126392\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD38XnvFCks7w%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Acetate%20utilization%20and%20butyryl%20coenzyme%20A%20%28CoA%29%3Aacetate-CoA%20transferase%20in%20butyrate-producing%20bacteria%20from%20the%20human%20large%20intestine&amp;journal=Appl%20Environ%20Microbiol&amp;doi=10.1128%2FAEM.68.10.5186-5190.2002&amp;volume=68&amp;pages=5186-5190&amp;publication_year=2002&amp;author=Duncan%2CSH&amp;author=Barcenilla%2CA&amp;author=Stewart%2CCS&amp;author=Pryde%2CSE&amp;author=Flint%2CHJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Lanjekar VB, Marathe NP, Ramana VV, Shouche YS, Ranade DR. <i>Megasphaera indica</i> sp. nov., an obligate anaerobic bacteria isolated from human faeces. Int J Syst Evol Microbiol. 2014;64:2250–6.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1099%2Fijs.0.059816-0\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24711592\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BC2cnhsV2qug%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Megasphaera%20indica%20sp.%20nov.%2C%20an%20obligate%20anaerobic%20bacteria%20isolated%20from%20human%20faeces&amp;journal=Int%20J%20Syst%20Evol%20Microbiol&amp;doi=10.1099%2Fijs.0.059816-0&amp;volume=64&amp;pages=2250-2256&amp;publication_year=2014&amp;author=Lanjekar%2CVB&amp;author=Marathe%2CNP&amp;author=Ramana%2CVV&amp;author=Shouche%2CYS&amp;author=Ranade%2CDR\">\n                    Google Scholar</a> \n                </p></li><li><p>Prabhu R, Altman E, Eiteman MA. Lactate and acrylate metabolism by <i>Megasphaera elsdenii</i> under batch and steady-state conditions. Appl Environ Microbiol. 2012;78:8564–70.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1128%2FAEM.02443-12\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23023753\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502912\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC38Xhslyjsr%2FJ\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Lactate%20and%20acrylate%20metabolism%20by%20Megasphaera%20elsdenii%20under%20batch%20and%20steady-state%20conditions&amp;journal=Appl%20Environ%20Microbiol&amp;doi=10.1128%2FAEM.02443-12&amp;volume=78&amp;pages=8564-8570&amp;publication_year=2012&amp;author=Prabhu%2CR&amp;author=Altman%2CE&amp;author=Eiteman%2CMA\">\n                    Google Scholar</a> \n                </p></li><li><p>Brenner DM, Corsetti M, Drossman D, Tack J, Wald A. Perceptions, definitions, and therapeutic interventions for occasional constipation: a Rome working group consensus document. Clin Gastroenterol Hepatol. 2024;22:397–412.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cgh.2023.08.044\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37797905\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Perceptions%2C%20definitions%2C%20and%20therapeutic%20interventions%20for%20occasional%20constipation%3A%20a%20Rome%20working%20group%20consensus%20document&amp;journal=Clin%20Gastroenterol%20Hepatol&amp;doi=10.1016%2Fj.cgh.2023.08.044&amp;volume=22&amp;pages=397-412&amp;publication_year=2024&amp;author=Brenner%2CDM&amp;author=Corsetti%2CM&amp;author=Drossman%2CD&amp;author=Tack%2CJ&amp;author=Wald%2CA\">\n                    Google Scholar</a> \n                </p></li><li><p>Høgsgaard K, et al. Fucose modifies short chain fatty acid and H<sub>2</sub>S formation through alterations of microbial cross-feeding activities. FEMS Microbiol Ecol. 2023;99: fiad107.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Ffemsec%2Ffiad107\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37777844\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561710\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Fucose%20modifies%20short%20chain%20fatty%20acid%20and%20H2S%20formation%20through%20alterations%20of%20microbial%20cross-feeding%20activities&amp;journal=FEMS%20Microbiol%20Ecol&amp;doi=10.1093%2Ffemsec%2Ffiad107&amp;volume=99&amp;publication_year=2023&amp;author=H%C3%B8gsgaard%2CK\">\n                    Google Scholar</a> \n                </p></li><li><p>Xu Y, Zhu Y, Li X, Sun B. Dynamic balancing of intestinal short-chain fatty acids: the crucial role of bacterial metabolism. Trends Food Sci Technol. 2020;100:118–30.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.tifs.2020.02.026\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXosVSrtr0%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Dynamic%20balancing%20of%20intestinal%20short-chain%20fatty%20acids%3A%20the%20crucial%20role%20of%20bacterial%20metabolism&amp;journal=Trends%20Food%20Sci%20Technol&amp;doi=10.1016%2Fj.tifs.2020.02.026&amp;volume=100&amp;pages=118-130&amp;publication_year=2020&amp;author=Xu%2CY&amp;author=Zhu%2CY&amp;author=Li%2CX&amp;author=Sun%2CB\">\n                    Google Scholar</a> \n                </p></li><li><p>Medlock GL, et al. Inferring metabolic mechanisms of interaction within a defined gut microbiota. Cell Syst. 2018;7:245-257.e7.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cels.2018.08.003\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30195437\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166237\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXhvVSnu73E\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Inferring%20metabolic%20mechanisms%20of%20interaction%20within%20a%20defined%20gut%20microbiota&amp;journal=Cell%20Syst&amp;doi=10.1016%2Fj.cels.2018.08.003&amp;volume=7&amp;pages=245-257.e7&amp;publication_year=2018&amp;author=Medlock%2CGL\">\n                    Google Scholar</a> \n                </p></li><li><p>Akhtar M, et al. Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation. Anim Nutr. 2022;8:350–60.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.aninu.2021.11.005\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35510031\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB38XovFShu70%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Gut%20microbiota-derived%20short%20chain%20fatty%20acids%20are%20potential%20mediators%20in%20gut%20inflammation&amp;journal=Anim%20Nutr&amp;doi=10.1016%2Fj.aninu.2021.11.005&amp;volume=8&amp;pages=350-360&amp;publication_year=2022&amp;author=Akhtar%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Vital M, Karch A, Pieper DH. Colonic butyrate-producing communities in humans: an overview using omics data. mSystems. 2017. <a target=\"_blank\" href=\"https://doi.org/10.1128/msystems.00130-17\">https://doi.org/10.1128/msystems.00130-17</a>.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1128%2Fmsystems.00130-17\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29238752\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715108\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Colonic%20butyrate-producing%20communities%20in%20humans%3A%20an%20overview%20using%20omics%20data&amp;journal=mSystems&amp;doi=10.1128%2Fmsystems.00130-17&amp;publication_year=2017&amp;author=Vital%2CM&amp;author=Karch%2CA&amp;author=Pieper%2CDH\">\n                    Google Scholar</a> \n                </p></li><li><p>Muñoz-Tamayo R, et al. Kinetic modelling of lactate utilization and butyrate production by key human colonic bacterial species. FEMS Microbiol Ecol. 2011;76:615–24.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1111%2Fj.1574-6941.2011.01085.x\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21388423\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Kinetic%20modelling%20of%20lactate%20utilization%20and%20butyrate%20production%20by%20key%20human%20colonic%20bacterial%20species&amp;journal=FEMS%20Microbiol%20Ecol&amp;doi=10.1111%2Fj.1574-6941.2011.01085.x&amp;volume=76&amp;pages=615-24&amp;publication_year=2011&amp;author=Mu%C3%B1oz-Tamayo%2CR\">\n                    Google Scholar</a> \n                </p></li><li><p>Ghiamati Yazdi F, et al. Long-term daily high-protein, drained yoghurt consumption alters abundance of selected functional groups of the human gut microbiota and fecal short-chain fatty acid profiles in a cohort of overweight and obese women. J Funct Foods. 2022;93: 105089.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.jff.2022.105089\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhslyqsL%2FK\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Long-term%20daily%20high-protein%2C%20drained%20yoghurt%20consumption%20alters%20abundance%20of%20selected%20functional%20groups%20of%20the%20human%20gut%20microbiota%20and%20fecal%20short-chain%20fatty%20acid%20profiles%20in%20a%20cohort%20of%20overweight%20and%20obese%20women&amp;journal=J%20Funct%20Foods&amp;doi=10.1016%2Fj.jff.2022.105089&amp;volume=93&amp;publication_year=2022&amp;author=Ghiamati%20Yazdi%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>Falony G, et al. Population-level analysis of gut microbiome variation. Science. 2016;352:560–4.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1126%2Fscience.aad3503\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27126039\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC28Xms1Kisbo%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Population-level%20analysis%20of%20gut%20microbiome%20variation&amp;journal=Science&amp;doi=10.1126%2Fscience.aad3503&amp;volume=352&amp;pages=560-4&amp;publication_year=2016&amp;author=Falony%2CG\">\n                    Google Scholar</a> \n                </p></li><li><p>González S, et al. Fermented dairy foods: impact on intestinal microbiota and health-linked biomarkers. Front Microbiol. 2019. <a target=\"_blank\" href=\"https://doi.org/10.3389/fmicb.2019.01046\">https://doi.org/10.3389/fmicb.2019.01046</a>.</p><p><a target=\"_blank\" href=\"https://doi.org/10.3389%2Ffmicb.2019.01046\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32047480\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854032\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Fermented%20dairy%20foods%3A%20impact%20on%20intestinal%20microbiota%20and%20health-linked%20biomarkers&amp;journal=Front%20Microbiol&amp;doi=10.3389%2Ffmicb.2019.01046&amp;publication_year=2019&amp;author=Gonz%C3%A1lez%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Guse K, et al. Regular consumption of lacto-fermented vegetables has greater effects on the gut metabolome compared with the microbiome. Gut Microbiome. 2023;4: e11.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1017%2Fgmb.2023.9\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39295909\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406409\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Regular%20consumption%20of%20lacto-fermented%20vegetables%20has%20greater%20effects%20on%20the%20gut%20metabolome%20compared%20with%20the%20microbiome&amp;journal=Gut%20Microbiome&amp;doi=10.1017%2Fgmb.2023.9&amp;volume=4&amp;publication_year=2023&amp;author=Guse%2CK\">\n                    Google Scholar</a> \n                </p></li><li><p>Xu S, et al. MicrobiotaProcess: a comprehensive R package for deep mining microbiome. Innov Camb Mass. 2023;4: 100388.</p><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXktVWqt7c%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=MicrobiotaProcess%3A%20a%20comprehensive%20R%20package%20for%20deep%20mining%20microbiome&amp;journal=Innov%20Camb%20Mass&amp;volume=4&amp;publication_year=2023&amp;author=Xu%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Harakeh S, et al. Impact of smoking cessation, coffee and bread consumption on the intestinal microbial composition among Saudis: a cross-sectional study. PLoS One. 2020;15: e0230895.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1371%2Fjournal.pone.0230895\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32348307\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190147\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXptVSjtbs%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Impact%20of%20smoking%20cessation%2C%20coffee%20and%20bread%20consumption%20on%20the%20intestinal%20microbial%20composition%20among%20Saudis%3A%20a%20cross-sectional%20study&amp;journal=PLoS%20One&amp;doi=10.1371%2Fjournal.pone.0230895&amp;volume=15&amp;publication_year=2020&amp;author=Harakeh%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Gänzle MG. Lactic metabolism revisited: metabolism of lactic acid bacteria in food fermentations and food spoilage. Curr Opin Food Sci. 2015;2:106–17.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cofs.2015.03.001\">Article</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Lactic%20metabolism%20revisited%3A%20metabolism%20of%20lactic%20acid%20bacteria%20in%20food%20fermentations%20and%20food%20spoilage&amp;journal=Curr%20Opin%20Food%20Sci&amp;doi=10.1016%2Fj.cofs.2015.03.001&amp;volume=2&amp;pages=106-117&amp;publication_year=2015&amp;author=G%C3%A4nzle%2CMG\">\n                    Google Scholar</a> \n                </p></li><li><p>Yoshikawa S, et al. Thermophile-fermented feed modulates the gut microbiota related to lactate metabolism in pigs. J Appl Microbiol. 2024;135: lxae254.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fjambio%2Flxae254\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39333026\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB2MXitFahsLrF\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Thermophile-fermented%20feed%20modulates%20the%20gut%20microbiota%20related%20to%20lactate%20metabolism%20in%20pigs&amp;journal=J%20Appl%20Microbiol&amp;doi=10.1093%2Fjambio%2Flxae254&amp;volume=135&amp;publication_year=2024&amp;author=Yoshikawa%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Iino T, Mori K, Tanaka K, Suzuki K, Harayama S. <i>Oscillibacter valericigenes</i> gen. nov., sp. nov., a valerate-producing anaerobic bacterium isolated from the alimentary canal of a Japanese corbicula clam. Int J Syst Evol Microbiol. 2007;57:1840–5.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1099%2Fijs.0.64717-0\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17684268\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Oscillibacter%20valericigenes%20gen.%20nov.%2C%20sp.%20nov.%2C%20a%20valerate-producing%20anaerobic%20bacterium%20isolated%20from%20the%20alimentary%20canal%20of%20a%20Japanese%20corbicula%20clam&amp;journal=Int%20J%20Syst%20Evol%20Microbiol&amp;doi=10.1099%2Fijs.0.64717-0&amp;volume=57&amp;pages=1840-1845&amp;publication_year=2007&amp;author=Iino%2CT&amp;author=Mori%2CK&amp;author=Tanaka%2CK&amp;author=Suzuki%2CK&amp;author=Harayama%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Bircher L, Schwab C, Geirnaert A, Lacroix C. Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology. Microb Biotechnol. 2018;11:163–75.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1111%2F1751-7915.12844\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28980453\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXjtFCnuw%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Cryopreservation%20of%20artificial%20gut%20microbiota%20produced%20with%20in%20vitro%20fermentation%20technology&amp;journal=Microb%20Biotechnol&amp;doi=10.1111%2F1751-7915.12844&amp;volume=11&amp;pages=163-175&amp;publication_year=2018&amp;author=Bircher%2CL&amp;author=Schwab%2CC&amp;author=Geirnaert%2CA&amp;author=Lacroix%2CC\">\n                    Google Scholar</a> \n                </p></li><li><p>Macfarlane GT, Macfarlane S, Gibson GR. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol. 1998;35:180–7.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1007/s002489900072\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9541554\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DyaK1cXitFynsbk%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Validation%20of%20a%20three-stage%20compound%20continuous%20culture%20system%20for%20investigating%20the%20effect%20of%20retention%20time%20on%20the%20ecology%20and%20metabolism%20of%20bacteria%20in%20the%20human%20colon&amp;journal=Microb%20Ecol&amp;doi=10.1007%2Fs002489900072&amp;volume=35&amp;pages=180-187&amp;publication_year=1998&amp;author=Macfarlane%2CGT&amp;author=Macfarlane%2CS&amp;author=Gibson%2CGR\">\n                    Google Scholar</a> \n                </p></li><li><p>Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal. 2011;17:10–2.</p><p><a target=\"_blank\" href=\"https://doi.org/10.14806%2Fej.17.1.200\">Article</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Cutadapt%20removes%20adapter%20sequences%20from%20high-throughput%20sequencing%20reads&amp;journal=EMBnet.journal&amp;doi=10.14806%2Fej.17.1.200&amp;volume=17&amp;pages=10-12&amp;publication_year=2011&amp;author=Martin%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Callahan BJ, et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–3.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnmeth.3869\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27214047\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927377\">PubMed Central</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC28XosVWitb4%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=DADA2%3A%20high-resolution%20sample%20inference%20from%20Illumina%20amplicon%20data&amp;journal=Nat%20Methods&amp;doi=10.1038%2Fnmeth.3869&amp;volume=13&amp;pages=581-3&amp;publication_year=2016&amp;author=Callahan%2CBJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Murali A, Bhargava A, Wright ES. IDTAXA: a novel approach for accurate taxonomic classification of microbiome sequences. Microbiome. 2018;6: 140.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1186/s40168-018-0521-5\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30092815\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085705\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=IDTAXA%3A%20a%20novel%20approach%20for%20accurate%20taxonomic%20classification%20of%20microbiome%20sequences&amp;journal=Microbiome&amp;doi=10.1186%2Fs40168-018-0521-5&amp;volume=6&amp;publication_year=2018&amp;author=Murali%2CA&amp;author=Bhargava%2CA&amp;author=Wright%2CES\">\n                    Google Scholar</a> \n                </p></li><li><p>Quast C, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590–6.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fnar%2Fgks1219\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23193283\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC38XhvV2ksb%2FN\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20SILVA%20ribosomal%20RNA%20gene%20database%20project%3A%20improved%20data%20processing%20and%20web-based%20tools&amp;journal=Nucleic%20Acids%20Res&amp;doi=10.1093%2Fnar%2Fgks1219&amp;volume=41&amp;pages=D590-D596&amp;publication_year=2013&amp;author=Quast%2CC\">\n                    Google Scholar</a> \n                </p></li><li><p>Stevenson DM, Weimer PJ. Dominance of <i>Prevotella</i> and low abundance of classical ruminal bacterial species in the bovine rumen revealed by relative quantification real-time PCR. Appl Microbiol Biotechnol. 2007;75:165–74.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1007/s00253-006-0802-y\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17235560\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXks1ahurk%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Dominance%20of%20Prevotella%20and%20low%20abundance%20of%20classical%20ruminal%20bacterial%20species%20in%20the%20bovine%20rumen%20revealed%20by%20relative%20quantification%20real-time%20PCR&amp;journal=Appl%20Microbiol%20Biotechnol&amp;doi=10.1007%2Fs00253-006-0802-y&amp;volume=75&amp;pages=165-174&amp;publication_year=2007&amp;author=Stevenson%2CDM&amp;author=Weimer%2CPJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Stoddard SF, Smith BJ, Hein R, Roller BRK, Schmidt TM. RrnDB: improved tools for interpreting rRNA gene abundance in bacteria and archaea and a new foundation for future development. Nucleic Acids Res. 2015;43:D593-598.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fnar%2Fgku1201\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25414355\">PubMed</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtV2isbjM\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=RrnDB%3A%20improved%20tools%20for%20interpreting%20rRNA%20gene%20abundance%20in%20bacteria%20and%20archaea%20and%20a%20new%20foundation%20for%20future%20development&amp;journal=Nucleic%20Acids%20Res&amp;doi=10.1093%2Fnar%2Fgku1201&amp;volume=43&amp;pages=D593-598&amp;publication_year=2015&amp;author=Stoddard%2CSF&amp;author=Smith%2CBJ&amp;author=Hein%2CR&amp;author=Roller%2CBRK&amp;author=Schmidt%2CTM\">\n                    Google Scholar</a> \n                </p></li><li><p>Dalgaard LB, et al. No effects of high versus low protein breakfast on body composition and cardiometabolic health in young women with overweight - the NewStart randomized trial. Br J Nutr. 2014;1–30. <a target=\"_blank\" href=\"https://doi.org/10.1017/S0007114524003015\">https://doi.org/10.1017/S0007114524003015</a>.</p></li><li><p>Lahti L, Shetty S (2012–2019). “microbiome R package.” Version 1.23.1. URL: <a target=\"_blank\" href=\"http://microbiome.github.com/microbiome\">http://microbiome.github.com/microbiome</a>, Bioconductor.</p></li><li><p>Kassambara A. rstatix: pipe-friendly framework for basic statistical tests. 2023. <a target=\"_blank\" href=\"https://github.com/kassambara/rstatix\">https://github.com/kassambara/rstatix</a>.</p></li><li><p>Oksanen J, et al. vegan: community ecology package. 2024. <a target=\"_blank\" href=\"https://vegandevs.r-universe.dev/vegan\">https://vegandevs.r-universe.dev/vegan</a>.</p></li></ol><p><a target=\"_blank\" href=\"https://citation-needed.springer.com/v2/references/10.1186/s40168-025-02207-6?format=refman&amp;flavour=references\">Download references</a></p></div></div>",
  "author": "Schwab, Clarissa",
  "favicon": "https://microbiomejournal.biomedcentral.com/oscar-static/img/favicons/darwin/favicon-de0c289efe.ico",
  "source": "microbiomejournal.biomedcentral.com",
  "published": "2025-10-21",
  "ttr": 1814,
  "type": "article"
}